Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Stanford Profiles: /viewCV - CAP Network
Document related concepts
Transcript
CURRICULUM VITAE DEAN L. WINSLOW, M.D. APPOINTMENTS AT STANFORD 09/01/2015- present Professor of Medicine Division of General Medical Disciplines Vice Chair, Department of Medicine Academic Physician-In-Chief, Stanford/ValleyCare 6/16/2014 - 8/31/2016 Clinical Professor of Medicine and Pediatrics Division of General Medical Disciplines 9/20/2013 - 6/15/2014 Clinical Professor of Medicine Division of Infectious Diseases and Geographic Medicine 9/01/2006 - 8/12/2013 Clinical Professor (Affiliated) of Medicine Division of Infectious Diseases and Geographic Medicine 9/01/2004 - 8/31/2006 Clinical Professor of Medicine Division of Infectious Diseases and Geographic Medicine 9/01/2003 – 8/31/2004 Clinical Professor (Affiliated) of Medicine Division of Infectious Diseases and Geographic Medicine 9/01/1998 – 8/31/2003 Adjunct Clinical Professor of Medicine Division of Infectious Diseases and Geographic Medicine EDUCATION 1972 – 1976 Jefferson Medical College, Philadelphia, Pennsylvania M.D. awarded in 1976, first fifth of class (Alpha Omega Alpha) 1971 – 1973 Pennsylvania State University, University Park, Pennsylvania B.S. in Science (with high distinction) awarded in 1974, (Penn State - Jefferson Medical College five-year cooperative program) 1967 – 1971 Dover High School, Dover, Delaware (valedictorian) INTERNSHIP, RESIDENCY AND SUBSPECIALTY TRAINING 1979 – 1981 Fellowship in Infectious Diseases at Ochsner Clinic and Ochsner Foundation Hospital, New Orleans, Louisiana 1977 – 1979 Residency in Internal Medicine at the Medical Center of Delaware, Wilmington, Delaware Dean L. Winslow, M.D. Curriculum Vitae - Page 2 1976 – 1977 Medical Internship at the Medical Center of Delaware, Wilmington, Delaware BOARD CERTIFICATION Board certified in Infectious Disease (November 1982, re-certified January 2013), American Board of Internal Medicine Board certified in Internal Medicine (September 1979), American Board of Internal Medicine Advanced Cardiac Life Support (exp. 2018) Advanced Trauma Life Support (exp. 2019) MEDICAL LICENSURES Licensed by the State of California, 1998 Licensed by the State of Maryland, 1990 Licensed by the State of Louisiana, 1979 Licensed by the State of Delaware, 1978 National Board of Medical Examiners, diplomate, 1977 PREVIOUS PROFESSIONAL PRACTICE AND ACADEMIC APPOINTMENTS June 2011—Aug 2013 Chair, Department of Medicine Santa Clara Valley Medical Center San Jose, CA July 2009—June 2011 Vice Chair, Department of Medicine Santa Clara Valley Medical Center San Jose, California Nov 2003 –Jan 2012 Chief, Division of AIDS Medicine and Director, PACE Clinic Santa Clara Valley Medical Center San Jose, California July 2003 –Nov 2008 Co-Director, Infectious Diseases Fellowship Training Program Stanford University School of Medicine Stanford, California Feb 2003-Nov 2003 Senior Medical Adviser Scientific and Medical Affairs Nucleic Acid Diagnostics Bayer Healthcare Berkeley, California Mar 1999 – Feb 2003 Vice President Regulatory Affairs and Clinical Research Visible Genetics, Inc. Toronto, Canada Dean L. Winslow, M.D. Curriculum Vitae - Page 3 Sept 1997 – Mar 1999 Director Clinical Research Gilead Sciences Foster City, California Mar 1996 – Sept 1997 Director Medical Affairs Group Clinical Affairs Agouron Pharmaceuticals, Inc. La Jolla, California 1996 – 1997 Clinical Professor of Medicine University of California San Diego School of Medicine La Jolla, California Jan 1994 –Mar 1996 Director Oncology and Virology Clinical Research and Development DuPont Merck Pharmaceutical Company Wilmington, Delaware July 1986 – Mar 1996 Head, Section of Infectious Diseases Department of Medicine Medical Center of Delaware Wilmington, Delaware Jan 1986 –Mar 1996 Director AIDS Clinic Medical Center of Delaware Wilmington, Delaware 1994 – 1996 Clinical Professor of Medicine Jefferson Medical College Philadelphia, Pennsylvania Jan 1986 –Mar 1996 Medical Director Blood Bank of Delaware Newark, Delaware Jan 1991 –July 1994 Principal Research Scientist Viral Diseases Research and Associate Medical Director Oncology and Virology DuPont Merck Pharmaceutical Company Wilmington, Delaware Jan 1990 –Jan 1991 Principal Research Scientist Viral Diseases Research E.I. DuPont de Nemours & Co., Inc. Central Research & Development Department Wilmington, Delaware 1989 – 1995 Associate Investigator Community Programs for Clinical Research on AIDS, NIAID (NIH) 1988 – 1994 Clinical Associate Professor of Medicine Dean L. Winslow, M.D. Curriculum Vitae - Page 4 Jefferson Medical College Philadelphia, Pennsylvania July1988 –Jan 1990 Associate Medical Director Infectious Diseases and Immunology E.I. DuPont de Nemours & Company, Inc. Medical Products Department Pharmaceuticals Division Wilmington, Delaware 1986 – 1994 Consultant Staff Infectious Diseases Stockley Center Georgetown, Delaware 1982 – 1988 Clinical Assistant Professor Medicine Jefferson Medical College Philadelphia, Pennsylvania July 1981 –Sept 1988 Private Practice Internal Medicine and Infectious Diseases Wilmington, Delaware 1981 – 1988 Consultant Staff Internal Medicine and Infectious Diseases Alfred I. DuPont Institute/Nemours Children’s Hospital Wilmington, Delaware Mar 1981 – June 1981 Assistant Staff Physician Department of Internal Medicine Section of Infectious Diseases Ochsner Clinic and Ochsner Foundation Hospital New Orleans, Louisiana 1979 – 1981 Clinical Instructor in Medicine Tulane University School of Medicine New Orleans, Louisiana Jan 1978 – Dec 1979 Staff Emergency Room Physician Kent General Hospital Dover, Delaware June 1968 –Sept 1970 Clinical Laboratory Technician (Summer/Weekends) Department of Pathology Kent General Hospital Dover, Delaware Dean L. Winslow, M.D. Curriculum Vitae - Page 5 MILITARY SERVICE Oct 1980 – Dec 2015 Rank – Colonel, USAF, MC (Brigadier General select) Final Assignment: Special assistant to the Adjutant General, Delaware National Guard Aeronautical Rating: Chief Flight Surgeon (primary aircraft assignment: F-4C Phantom II 1981-1985, F-15 Eagle 1985 - 1995, C-130H Hercules 1995 – 2015) Total civilian + military flying hours: 3600 (431 combat hours) Key previous assignments: - Flight Surgeon, 122nd Tactical Fighter Squadron, Louisiana ANG (1980-1989) - Chief of Aerospace Medicine, 159th Medical Group, Louisiana ANG (19891992) - Commander, 159th Medical Group, Louisiana ANG (1992-1995) - Commander, 447th Expeditionary Medical Squadron, Baghdad, Iraq (2008) - State Air Surgeon, Delaware Air National Guard (1995-2011) - Air National Guard Assistant to the Commander, 59th Medical Wing (20112014) PROFESSIONAL COMMITTEES 2017-present Healthcare Infection Control Practices Advisory Committee (HICPAC), Centers for Disease Control and Prevention (CDC) 2011-present Standards and Practice Guidelines Committee, Infectious Diseases Society of America (Chair 2015-present) 2014-present Board of Regents, California Institute of Medical Research 2009 – 2011 Chair, Santa Clara Valley Medical Center Medicine QI and Peer Evaluation Committee 2007 – 2015 Stanford University School of Medicine Clinician Educator Appointment and Promotions Committee 2006 – present Stanford University Intern Selection Committee 2006 - present Stanford University Residency Review Committee 2003 – 2013 Santa Clara Valley Medical Center Infection Control Committee 1990 – 2015 Consultant (Infectious Diseases) to the Surgeon General, United States Air Force 1996 – 1999 Chairman, Virology Subcommittee, Inter-Company Collaboration for AIDS Drug Development 1994 – 1998 Clinical Trial Subcommittee, Inter-Company Collaboration for AIDS Drug Development 1994 – 1995 Scientific Agenda Committee, CPCRA/NIAID/NIH 1993 – 1996 Advisory Board, Medical Eye Bank of Delaware 1992 – 1996 Medical Advisory Committee, Planned Parenthood of Delaware Dean L. Winslow, M.D. Curriculum Vitae - Page 6 1992 – 1994 Chairman, National Institutes of Health/National Institute of Allergy and Infectious Diseases, Community Programs for Clinical Research on AIDS, Vaccine Working Group 1990 – 2003 National Institutes of Health/National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Research Review Committee (Study section member). 1990 – 1996 Co-Chairman, NIH/NIAID, Community Programs for Clinical Research on AIDS, Combination Nucleoside Protocol Committee 1990 – 1994 NIH/NIAID, CPCRA, Antiretroviral Working Group 1990 – 1994 NIH/NIAID, CPCRA, Surrogate Markers Subcommittee 1990 – 1994 Supreme Court of Delaware, Board on Professional Responsibility 1989 – 1990 Arthritis Foundation Medical and Scientific Committee 1989 – 1990 Supreme Court of Delaware, Committee on Judicial Problems Relating to AIDS 1988 – 1989 E.I. DuPont de Nemours & Co., Inc. Strategic Planning Team - Infectious Diseases/Cancer 1986 – 1996 Medical Center of Delaware Executive Committee, Department of Medicine 1986 – 1994 Governor's AIDS Task Force, State of Delaware, Division of Public Health 1985 – 1994 Blood Bank of Delaware Medical Advisory Committee 1984 – 1985 Advisory Committee on Tuberculosis, State of Delaware Division of Public Health 1981 – 1988 Medical Center of Delaware Antimicrobial Surveillance Committee (Chairman 1987-1988) 1981 – 1988 Medical Center of Delaware Infection Control Committee 1981 – 1988 Medical Center of Delaware Education Committee, Department of Medicine 1981 – 1988 St. Francis Hospital Infection Control Committee TEACHING 2013—present Resident Fellow, Robinson House Stanford University Dean L. Winslow, M.D. Curriculum Vitae - Page 7 2013- present Attending Physician, Universtiy Hospitalist Service, Stanford University School of Medicine 2003 – present Stanford University School of Medicine Teaching Attending, Division of Infectious Diseases and Inpatient (General) Medicine INDE-265 Microbiology and Infectious Diseases Medicine 300 Core Lecturer, “HIV from Bench to Bedside” and “Antibiotics, spectra, mechanisms of action and resistance, Medicine 302 Attending Physician/Preceptor, Medicine 313 Attending Physician/Preceptor, Pediatrics 300/Pediatric Infectious Diseases Teaching Rounds, SCVMC/LPCH, Human Health and Disease 222/223/224 CPC Discussant (twice yearly) 1998 – 2003 Stanford University School of Medicine Teaching Attending, Inpatient Infectious Diseases Consult Service, Stanford University Hospital and Attending Physician, Immune Clinic, VA Medical Center, Palo Alto 1996 – 1997 University of California San Diego Teaching Attending, Special Immunology Clinic, VA Medical Center, LaJolla 1988 – 1996 Mid-Atlantic AIDS Regional Education and Training Center Chairman/Principal Investigator, Delaware Area 1986 – 1994 Medical Center of Delaware Coordinator for Education, AIDS Clinic 1981 – 1996 Jefferson Medical College Lecturer, Infectious Diseases (Third Year, Internal Medicine Core Curricula) 1981 – 1988 Medical Center of Delaware Coordinator for Education, Adult Infectious Diseases (MCD Internal Medicine Residents and JMC Fourth Year Students) OTHER PROFESSIONAL ACTIVITIES 2010- present Board of Directors, Episcopal Chaplaincy, Stanford Hospital 1990 – 1991 Board of Directors, Wilmington Music School 1989 – 1992 Board of Directors, American Red Cross (Delaware) 1989 – 1990 Board of Directors, Arthritis Foundation (Delaware) 1989 – 1990 Board of Directors, Family Services of Delaware 1986 – 1994 Board of Directors, Blood Bank of Delaware 1982 – 1986 Board of Directors, Delaware Lung Association EDITORIAL ACTIVITIES: 1992 – 2016 Editorial Board, AIDS (London). 2003 – present Associate Editor, Infectious Disease Alert Dean L. Winslow, M.D. Curriculum Vitae - Page 8 2014- present Associate Editor, Diagnostic Microbiology and Infectious Disease 1990 – present Reviewer, AIDS (London) 1990 – present Reviewer, Journal of Infectious Diseases/Clinical Infectious Diseases 2013-- present Reviewer, Journal of Antimicrobial Chemotherapy 1993 Reviewer, Evaluation and Management of Early HIV Infection, Agency for Health Care Policy and Research (AHCPR) Department of Health and Human Services 1993 Reviewer, HIV/AIDS Research Agenda, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). 1991 – 1996 Reviewer, Antiviral Chemistry and Chemotherapy 1988 – 1991 Editorial Board, Delaware Medical Journal RESEARCH GRANT SUPPORT 1992 – 1997 HRSA/MAAETC grants renewed. (Principal Investigator, Delaware Area) 1989 – 1996 National Institutes of Health/National Institute of Allergy and Infectious Diseases Community Program for Clinical Research on AIDS - Associate Investigator (William Holloway, PI) 1987 – 1996 Health Resources Services Administration: Mid-Atlantic AIDS Regional Education and Training Center, Principal Investigator, Delaware Area. 1979 – 1981 Ochsner Foundation: In vitro studies of antimicrobial interactions with Listeria monocytogenes MEDICAL SOCIETIES Aerospace Medical Association American College of Physicians (Fellow) American Society for Microbiology Alliance of Air National Guard Flight Surgeons Association of Military Surgeons of the United States Infectious Diseases Society of America (Fellow) Medical Society of Delaware Pediatric Infectious Diseases Society Society of USAF Flight Surgeons HONORS AND AWARDS Dean L. Winslow, M.D. Curriculum Vitae - Page 9 2014, 2015 David A. Rytand award for excellence in clinical teaching, Department of Medicine, Stanford University School of Medicine 2011 Paul Harris Fellowship—Recognition for humanitarian service, Rotary International 2008 Award for humanitarian service to the people of Iraq-- Iraqi Army Ground Forces Command 2008 Teaching award, Iraqi Armed Forces Flight Surgeon Training Course 2007 Commendation for professionalism in commitment to patient welfare—American College of Physicians Ethics, Professionalism and Human Rights Committee 2006 George W. Bush Award, Air Force Association 1990 Fellow, Infectious Diseases Society of America 1988 Malcolm C. Grow Award, Outstanding U.S.A.F. flight surgeon (ANG Command) 1984 Fellow, American College of Physicians 1983 Distinguished graduate, U.S.A.F. School of Aerospace Medicine 1981 Trustee's Award for Original Medical Research (Ochsner Clinic and Ochsner Foundation Hospital) 1975 Alpha Omega Alpha (Jefferson Medical College) 1972 President's Award (Pennsylvania State University) 1971 – 1972 Varsity Track and Cross Country Teams (Pennsylvania State University) 1971 Valedictorian; Bausch & Lomb Award; Science Award; English Award; American Legion History Award: Student Council Award: Delaware All-State Orchestra, Varsity Football and Track (Dover High School) 1971 Co-Captain, Varsity Track Team (Dover High School) Military Decorations: Legion of Merit, Air Force Meritorious Service Medal with two oak leaf clusters, Air Medal with two oak leaf clusters, Aerial Achievement Medal with three oak leaf clusters, Air Force Commendation Medal with three oak leaf clusters, Air Force Combat Action Medal, Southwest Asia Service Medal with two bronze stars, Humanitarian Service Medal with one bronze star, Iraq Campaign Medal with four bronze stars, Afghanistan Campaign Medal with two bronze stars, Combat Readiness Medal, Global War on Terrorism Expeditionary Medal, Armed Forces Expeditionary Medal with one bronze star, National Defense Service Medal with one bronze star, Air Force Expeditionary Service Ribbon with Gold Border and four oak leaf clusters, Antarctica Service Medal, Armed Forces Reserve Medal with M device, Small Arms Expert Marksmanship Ribbon (M16/M4 rifle and M9 pistol), Delaware Conspicuous Service Cross, Louisiana Legion of Merit, Louisiana Emergency Service Medal, Mississippi Emergency Service Medal, NATO ISAF (Afghanistan) Medal. Dean L. Winslow, M.D. Curriculum Vitae - Page 10 Civilian Aeronautical Ratings: Airline Transport Pilot- Multiengine Land Aircraft (Boeing 737, Douglas DC-3 and L-29 Delfin jet type ratings), Commercial privileges- Single Engine Land Aircraft, Private privileges- Glider (aero tow). RESEARCH ACTIVITY 2003 – 2013 Clinical Site Director at Santa Clara Valley Medical Center, Stanford AIDS Clinical Trial Unit, National Institute of Allergy and Infectious Diseases/NIH. 1999 – 2003 Vice President, Regulatory Affairs and Clinical Research: Formulation of regulatory strategy, development and execution of clinical development plan for an integrated genotyping system for drug resistance testing of HIV-1, Hepatitis B and Hepatitis C viruses, and overall responsibility for completion of a 37 volume 510(k) submission to FDA and related marketing applications in Canada, Europe, and Latin America. In addition, created and directed Medical Affairs/Medical Information group (Visible Genetics, Inc.) 1997 – 1999 Director, Clinical Research: Supervision of Phase I-IV clinical trials of adefovir dipivoxil for HIV disease indication, leader of clinical NDA team. (Gilead Sciences) 1996 – 1997 Director, Medical Affairs Group, Clinical Affairs: Responsible for Phase IIIB and Phase IV trials of nelfinavir (AG1343) HIV protease inhibitor, Expanded Access Program (Adult and Pediatric), post-marketing adverse experience reporting, and drug information services. In addition, served as leader of clinical NDA team. (Agouron Pharmaceuticals). 1992 – 1996 International Project Clinician and Project Team Leader: Supervision of Phase IIII clinical trials and overall management of losoxantrone (DuP 941), and bisnafide (DMP 840), antineoplastic agents. (DuPont Merck Clinical Research). 1994 – 1996 International Project Clinician. Development of clinical research plans, protocol design, and supervision of clinical trials of DMP450 HIV protease inhibitor and DMP266 (efavirenz) non-nucleoside reverse transcriptase inhibitor. Designed all studies eventually used to support efavirenz NDA including single and multiple dose PK studies, drug interaction studies, safety and efficacy trials (e.g. Study 006) (DuPont Merck Clinical Research). 1992 – 1996 Principal Investigator: Construction and characterization of infectious molecular clones of HIV-1 containing defined mutations in the HIV protease and RT genes using oligonucleotide-directed mutagenesis. (DuPont Merck Virology Research). 1992 – 1993 International Project Clinician: Development of clinical research plans, protocol design, and clinical supervision of DMP 323 (HIV protease inhibitor) studies in patients with HIV infection. (DuPont Merck Clinical Research). 1990 – 1994 Principal Investigator: Characterization of HIV-1 clinical isolates by polymerase chain reaction amplification of protease gene and direct nucleotide sequencing (DuPont Merck Virology Research). 1990 – 1995 Principal Investigator: Isolation of HIV-1 from infected patients and determination of in vitro susceptibility to antiviral agents including HIV protease inhibitors in development (DuPont Merck Virology Research). 1991 – 1996 Co-investigator (with M. Otto, L. Bacheler, R. King, and E. Cheng): Characterization of HIV-1 mutants selected in tissue culture with reduced in vitro Dean L. Winslow, M.D. Curriculum Vitae - Page 11 susceptibility to HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors. (DuPont Merck Virology Research). 1992 – 1996 Co-investigator (with D. Mayers, Walter Reed Army Institute of Research and H. Balfour, University of Minnesota): Prospective evaluation of resistance to nucleoside antiretroviral agents in patients participating in a clinical trial of combination nucleosides in HIV infection. (DuPont Merck Virology Research). 1988 – 1990 International Project Clinician: Development of clinical research plans, protocol design, and clinical supervision of Brequinar (DuP 785) studies in rheumatoid arthritis, psoriasis, and organ transplantation (DuPont Medical Research). 1989 – 1990 Project Clinician: Clinical supervision of a pilot study of lymphokine activated killer cells/IL-2/Zidovudine in HIV-infected patients (DuPont Medical Research). 1989 – 1990 Project Clinician: Protocol design and clinical supervision of a Phase I/II bioavailability, pharmacokinetic, safety, and efficacy study of Brequinar (DuP 785) in patients with histologically documented cancer (DuPont Medical Research). 1988 Project Clinician: Development of clinical research plan, protocol design, and clinical supervision of Ampligen studies in HIV infected patients (DuPont Medical Research). 1979 Prospective evaluation of an enzyme-linked immunosorbent assay (ELISA) to detect anti-mannan antibody in immunocompromised patients at risk for development of disseminated candidiasis (Co-investigator: In collaboration with R. Marier, M.D., LSU School of Medicine). 1980 Characterization of plasmids conferring resistance to aminoglycosides in Klebsiella pneumoniae causing epidemic infection in a neonatal I.C.U. (Coinvestigator: In collaboration with R. O'Callaghan, Ph.D., LSU School of Medicine). BIBLIOGRAPHY Abstracts 1. Winslow DL. In Vitro Activity of Trimethoprim and Sulfamethoxazole Against Listeria monocytogenes. Abstract #618, presented at 20th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, September 23, 1980. 2. Winslow DL, Pankey GA. In Vitro Activity of Antimicrobial Combinations Containing Rifampin or Trimethoprim against Listeria monocytogenes. Abstract #A-3, presented at 81st Annual Meeting of the American Society for Microbiology, Dallas, Texas, March 2, 1981. 3. Winslow DL, Pike PL, Holloway WJ. Comparative In Vitro Activities of Newer B-lactam Antibiotics Against Listeria monocytogenes. Abstract #A2, presented at 82nd Annual Meeting of the American Society for Microbiology, Atlanta, Georgia, March 8, 1982. 4. Winslow DL, Damme J, Dieckan E, Holloway WJ. Delayed Bactericidal Activity of B-lactam Antibiotics Against Listeria monocytogenes - Antagonism by Rifampin and Chloramphenicol. Abstract #224, presented at 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Miami, Florida, October 4-6, 1982. Dean L. Winslow, M.D. Curriculum Vitae - Page 12 5. Holloway WJ, Winslow DL, Reinhardt JF. Treatment of Gram-negative Bacteremia with Intravenous Trimethoprim and Sulfamethoxazole. Abstract #A-40, presented at 83rd Annual Meeting of the American Society for Microbiology, New Orleans, Louisiana, March 9, 1983. 6. Winslow DL, Bailey E, Holloway WJ. Effect of Newer B-lactam Antibiotics on the Bactericidal Activity of Ampicillin Against Listeria monocytogenes. Abstract #1056, Presented at the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., October 8-10, 1984. 7. Holloway WJ, Winslow DL, Bentsen C. Infection Due to Penicillin-insensitive Type 23 Pneumococcus, Abstract #A-1, Presented at the 85th Annual Meeting of the American Society for Microbiology, Las Vegas, Nevada, March 3-7, 1985. 8. Holloway WJ, Winslow DL, Reinhardt JF. Cefmetazole in Treatment of Serious Infections, Abstract #1225, Programs and Abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, October 1, 1986. 9. Winslow DL, Steele-Moore L, Furness K, Holloway WJ. Interaction of Beta-lactam Antibiotics and Meningeal Pathogens, Abstract #A-28, Programs and Abstracts of the 87th Annual Meeting of the American Society for Microbiology, Atlanta, Georgia, March 2, 1987. 10. Tribe D, Reed D, Lindell P, Winslow DL, Petteway S, et al. Serological Analysis of HIV gag Reactive Sera in a Donor Population Using Both Viral and Recombinant Antigens. Paper TP.85 Presented at the III International Conference on Acquired Immunodeficiency Syndrome (AIDS), Washington, D.C., June 1, 1987. 11. Winslow DL, Allen C, Reinhardt J, Lindell P, Travis R. Behavior Risk Factors and Clinical Features of Blood Donors Seropositive for HIV, Abstract #700, 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, New York City, New York, October 4, 1987. 12. Winslow DL, Allen C, Reinhardt JF, Lindell P, Travis R. Declining Incidence and Changing Behavioral Risk Factors of Blood Donors Seropositive for HIV, Abstract #7686, presented at IV International Conference on AIDS, Stockholm, Sweden, June 12-16, 1988. 13. Bach MC, Howell DA, Valenti AJ, Smith T, Dretler RH, Winslow DL. Aphthous Ulcerations of the Gastrointestinal Tract in Patients with AIDS, V International Conference on AIDS, Montreal, June 4-9, 1989. 14. Winslow DL, Bincsik A, Lincoln P, Smolka H, Holloway W. Secondary Prophylaxis of Pneumocystis Carinii Pneumonia with Systemic Pentamidine, V International Conference on AIDS, Montreal, June 4-9, 1989. 15. Weck PK, Dorian SM, Winslow DL, Ycas JW, Chao GC. Results of a Randomized Double-blind Clinical Trial of Ampligen, DuPont Bioscience Forum, Wilmington, Delaware, April 10-11, 1989. 16. Ycas JW, Winslow DL, Chao GC, Weck PK. The Risk of AIDS for ARC Patients: A Statistical Report on the AMP101 Trial, DuPont Bioscience Forum, Wilmington, Delaware, April 10-11, 1989. 17. Winslow DL, Lisi TB, Kim YS, Labriola DF, Zajac BA. Clinical Trials of DuP 785 in Rheumatoid Arthritis, DuPont Bioscience Forum, Wilmington, Delaware, March 26-27, 1990. 18. Farmer DL, Linna TJ, Smith JW, Winslow DL, Weck PK, Eberly VS, Zajac BA. Clinical Trials with Cellular Therapy, DuPont Bioscience Forum, Wilmington, Delaware, March 26-27, 1990. 19. Farmer DL, Winslow DL, Zajac BA. Clinical Trials for Novel Immunosuppressive Agents in Organ Transplantation, DuPont Bioscience Forum, Wilmington, Delaware, March 26-27, 1990. Dean L. Winslow, M.D. Curriculum Vitae - Page 13 20. Nonomura JH, Linna TJ, Kim YS, Winslow DL, Labriola DF, Zajac BA. Clinical Assessment of AntiInflammatory Dermatological Agents, DuPont Bioscience Forum, Wilmington, Delaware, March 26-27, 1990. 21. Donehower R, Noe D, Forestiere A, Grochow L, Ettinger D, Rowinsky E, McGuire W, Hendricks C, King P, Lisi T, Winslow DL. Phase I, Bioavailability, Pharmacokinetic Study of Oral Brequinar in Patients with Advanced Cancer, Annual Meeting of the American Society of Clinical Oncology, Houston, Texas, May 19-21, 1991. 22. King SP, Chi CL, Winslow DL, Lisi TB. Pharmacokinetics of Brequinar Sodium After Oral Dosing in Cancer Patients, DuPont Bioscience Forum Wilmington, Delaware, April 29-30, 1991. 23. Winslow DL, Lisi TB, King SP, Noe D, Donehower R. Phase I Bioavailability and Pharmacokinetics Study of Oral Brequinar in Patients with Advanced Cancer, DuPont Bioscience Forum, Wilmington, Delaware, April 29-30, 1991. 24. Winslow DL, Garber S, Reid C, Otto MJ. Isolation of HIV-1 from Peripheral Blood Mononuclear Cells. DuPont Bioscience Forum, Wilmington, Delaware, April 29-30, 1991. 25. Winslow DL, Bacheler LT, Stack S, Bincsik A, Swanson K, Otto MJ. Genotypic Diversity of HIV-1 Isolated from Mid-Atlantic United States. VIII International Conference on AIDS, Amsterdam, Netherlands, July 19-24, 1992. 26. Otto MJ, Garber S, Winslow DL, Cheng Y-SE, Reid CD, Jadhav PK. In vitro Isolation and Partial Characterization of HIV Variants with Reduced Sensitivity to C-2 Symmetrical Inhibitors of HIV-1 Protease. VIII International Conference on AIDS, Amsterdam, Netherlands, July 19-24, 1992. 27. Cheng Y-SE, Patterson CE, Buckery R, Otto MJ, Winslow DL. HIV-1 (rf) Variants with a Single Amino Acid Substitution in Protease (Val 82 to Ala) Have Reduced Sensitivity to C-2 Symmetrical Inhibitors of HIV-1 Protease. VIII International Conference on AIDS, Amsterdam, Netherlands, July 19-24, 1992. 28. Church T, Dehlinger M, Saravolatz L, Stein D, Winslow DL, Collins G. Design of a Randomized Trial of Combined Nucleoside Analog Antiretroviral Therapy in AIDS Patients. XIV Annual Meeting Society for Clinical Trials, Orlando, Florida, May 23-26, 1993. 29. Otto MJ, Reid CD, Garber S, Winslow DL, Scarnati H, Lam P, Ru Y. XM323, A Novel Cyclic Nonpeptidyl Inhibitor of HIV Protease with Potent In vitro Antiviral Activity. IX International Conference on AIDS, Berlin, Germany, June 7-11, 1993. 30. Winslow DL, Scarnati H, Otto MJ. In vitro Antiviral Activity of XM323 (Non-peptidyl) HIV Protease Inhibitor) Against Clinical Isolates of HIV-1. IX International Conference on AIDS, Berlin, Germany, June 7-11, 1993. 31. Bacheler L, Ackerman K, Sheridan P, Pachl C, Swanson K, Winslow DL. Quantitation of HIV Plasma Viremia Using the Branched DNA Signal Amplification and p24 Antigen Assays During Combination Nucleoside Antiviral Therapy. IX International Conference on AIDS, Berlin, Germany, June 8-11, 1993. 32. Otto MJ, Garber S, Stack S, Winslow DL. Reduced Sensitivity to HIV PR Inhibitors is Associated with Single Amino Acid Substitutions in HIV-1 PR. Second International Workshop on HIV Drug Resistance, Noordwijk, Netherlands, June 3-5, 1993. 33. Saravolatz L, Winslow DL, Stein D, Dehlinger M, Collins G, Church T, Deyton L. The Community Program for Clinical Research on AIDS (CPCRA): Design and Implementation of a Community Based Trial for the Comparison of Combination of ZDV with ddC or ddI to ZDV Monotherapy. First National Conference on Human Retroviruses and Related Infections, Washington, DC. December 12-16, 1993. Dean L. Winslow, M.D. Curriculum Vitae - Page 14 34. Otto MJ, Garber S, Stack S, King RW, Winslow DL. The Potency of XM323, a Cyclic Urea Inhibitor of HIV Protease is Marginally Affected by Amino Acid Substitutions at Position 82 of HIV-PR. Third Workshop on Viral Resistance, Gaithersburg, Maryland, September 19-22, 1993. 35. Winslow DL, Horlick RA, Anton ED, Tritch RJ, Zagursky R, Bacheler LT. A Novel Method for Construction of Infectious Molecular Clones of HIV-1 Containing Defined Mutations in the HIV Protease Gene. Third Workshop on Viral Resistance, Gaithersburg, Maryland, September 19-22, 1993. 36. Pieniaszek H, Lai C-M, Slichenmyer W, Finizio M, Winslow DL, Donehower R, VonHoff D. Clinical Pharmacokinetics of DMP 840, a Novel Bis-Napthalimide Anticancer Agent. 23rd Annual Meeting of the American College of Clinical Pharmacology, Orlando, Florida, October 6-8, 1994. 37. King RW, Winslow DL, Garber S, Scarnati H, Stack S, Otto MJ. Identification of a Clinical Isolate of HIV-1 from Northern Thailand with a Naturally Occurring Isoleucine at Position 82 of the Protease. Third International Workshop on HIV Drug Resistance, Kauai, Hawaii, August 2-5, 1994. 38. Anton ED, Bacheler LT, Horlick RA, Zagursky RJ, Tritch RJ, Winslow DL. A Method for Construction of Infectious Molecular Clones of HIV-1 Containing Defined Mutations in the HIV Protease Gene. Third International Workshop on HIV Drug Resistance, Kauai, Hawaii, August 2-5, 1994. 39. Winslow DL, Anton ED, Horlick RA, Zagursky RJ, Tritch RJ, Scarnati H, Ackerman K, Buckery R, Bacheler LT. Defined Mutations in the HIV Protease Gene Confer Reduced Susceptibility to Structurally Dissimilar HIV Protease Inhibitors. Third International Workshop on HIV Drug Resistance, Kauai, Hawaii, August 2-5, 1994. 40. Winslow DL, King R, Stack S, Scarnati H, Otto MJ. Limited Sequence Diversity of the HIV-1 Protease Gene from Clinical Isolates and in vitro Susceptibility to HIV Protease Inhibitors. Third International Workshop on HIV Drug Resistance, Kauai, Hawaii, August 2-5, 1994. 41. Otto MJ, Aldrich P, Grubb M, Shum L, Erickson-Viitanen S, Winslow DL. XM412: An Improved Cyclic Urea Inhibitor of HIV Protease for Oral Administration. X International Conference on AIDS, Yokohama, Japan, August 7-12, 1994. 42. Winslow DL, Anton E, Horlick R, Zagursky R, Tritch R, Scarnati H, Ackerman K, Otto M, Bacheler L. Variations at Amino Acid 82 in HIV-1 Protease Confer Reduced Sensitivity to Structurally Dissimilar HIV Protease Inhibitors. X International Conference on AIDS, Yokohama, Japan, August 7-12, 1994. 43. Saravolatz L, Winslow DL, Stein D, Dehlinger M, Collins G, Deyton L. Design and Implementation of a Community Based Trial for the Comparison of Combination ZDV with ddC or ddI to ZDV Monotherapy. X International Conference on AIDS, Yokohama, Japan, August 7-12, 1994. 44. Fosdick M, Winslow DL, Larsen S. Clinical Significance of MHA-TP as a Confirmatory Test for the Olympus PK-TP System. Annual Meeting of the American Association of Blood Banks. San Diego, CA. November 12-17 1994. 45. Fosdick M, Bonk D, Russell H, Travis R, Wilson S, Ycas J, Winslow DL. A Comparison of Test Marker Rates Between Allogeneic Donors and Replacement Donors. Annual Meeting of the American Association of Blood Banks. San Diego, CA. November 12-17 1994. 46. Bacheler LT, Gallagher K, Buckery R, Anton E, Scarnati H, Winslow DL. Sensitivity to Protease Inhibitors of Recombinant HIV's with Defined Mutations in the Protease Gene. 2nd National Conference on Human Retroviruses and Related Infections. Washington, DC January 29 - February 2 1995. 47. Alexander MA, Winslow DL, Anton E, Logue K, Bacheler LT. Detection of HIV Mutants Resistant to Protease Inhibitors by Solid-phase Non-radioactive Minisequencing. 2nd National Conference on Human Retroviruses and Related Infections. Washington, DC January 29 - February 2 1995. Dean L. Winslow, M.D. Curriculum Vitae - Page 15 48. Otto MJ, Reid CD, King RW, Garber S, Baker DB, Anton E, Winslow DL. Exposure of Chronically Infected PBMC's to DMP450 Can Completely Suppress Virus Replication or Select Resistant Variants Depending Upon the Dose of Compound. 2nd National Conference on Human Retroviruses and Related Infections. Washington, DC January 29 - February 2 1995. 49. Erickson-Viitanen S, Hodgem CN, Aldrich P, Bacheler LT, Chang C-H, Eyermann CJ, Jackson DA, Jadham PK, Korant BD, Lam PY-S, Maurin M, Meek JL, Otto MJ, Rayner MM, Sharpe TR, Shum L, Winslow DL. Cyclic Urea Inhibitors of HIV Protease, 2nd National Conference on Human Retroviruses and Related Infections. Washington, DC January 29 - February 2, 1995. 50. Winslow DL, Garber S, Reid C, Anton E, Otto MJ. DMP450, A New Cyclic Urea Inhibitor of HIV Protease with Potent In Vitro Antiviral Activity, 8th International Conference on Antiviral Research, Santa Fe, NM, April 23-28, 1995. 51. Vokes EE, O'Brien SM, Schilsky RL, Vogelzang NJ, Joshi A, Winslow DL, Ratain MJ. A Phase I Study of High-dose DuP 941 (losoxantrone) in Combination with Cyclophosphamide (CTX). American Society of Clinical Oncology Annual Meeting, Los Angeles, CA, May 20-23, 1995. 52. White S, Robinson C, Shum L, Kornhauser D, Carter R, Pieniaszek H, Quon C, Cohen I, Riddell J, Winslow DL. Pharmacokinetics, Safety, and Tolerance of DMP 450 Single Oral Doses in Healthy Male Subjects. Annual Meeting of the American College of Clinical Pharmacology. Rockville, MD September 21-23, 1995 53. Bacheler L, Alexander M, Anton E, Buckery R, Chang CH, Gallagher K, Jadhav PK, Logue K, Paul M, Wilkerson WW, Winslow DL. Drug Susceptibility and Growth Characteristics of Constructed HIVs with Defined Mutations in the Protease Gene. IV Conference on HIV Drug Resistance, Sardinia, Italy, July 6-9, 1995 54. Anton E, Bacheler L, Garber S, Reid C, Buckery R, Scarnati H, Korant B, Winslow DL. Replicative Ability of HIV Variants with Substitutions in the Active Site of Protease is Dependent on Compensatory Mutations Outside The Active Site. IV Conference on HIV Drug Resistance, Sardinia, Italy, July 6-9, 1995 55. Winslow DL, Garber S, Reid C, Scarnati H, Korant B, Emini E, Anton ED. Development of High Level Resistance to DMP 266 Requires Multiple Mutations in the Reverse Transcriptase Gene. IV Conference on HIV Drug Resistance, Sardinia, July 6-9, 1995 56. Anton ED, Bacheler L, Garber S, Reid C, Buckery R, Scarnati H, Baker D, Korant B, Winslow DL. Replicative Ability of Some HIV-I Variants with Substitutions in the Active Site of Protease are Dependent on Compensatory Mutations. Fourth Workshop on Viral Resistance, Annapolis, MD, September 10-12, 1995 57. Zybarth G, VerPlank L, Garber S, Winslow DL, Otto MJ, Carter CA. Domains Upstream of the Protease in HIV-I Gag-Pol May Contribute to Selection of Resistant Variants by Compensating for Negative Effects of Mutations in PR. Fourth Workshop on Viral Resistance, Annapolis, MD, September 10-12, 1995 58. Kraynak MA, Cobb PW, Rodriguez G, Eckardt J, Winslow DL, Joshi A, Burris HA. Phase I Trial of Losoxantrone in Combination With Paclitaxel in Patients With Refractory Maligancies. 9th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, March 12-15, 1996. 59. Saravolatz L, Collins G, Hodges J, Winslow DL, and the Community Programs for Clinical Research on AIDS 007 Protocol Team. A Randomized Comparative Trial of ZDV versus ZDV plus ddI versus ZDV plus dd C in Persons with CD4 Cell Counts of <200/mm3. 3rd National Conference on Retroviruses and Opportunistic Infections. Washington, DC, January 28- February 1, 1996. 60. Winslow DL, Reid C, Garber S, Scarnati H, Rayner M, Baker D, Anton ED. Selection Conditions Affect the Evolution of Specific Mutations In The Reverse Transcriptase Gene Associated with Resistance to DMP 266. Fifth International Workshop on HIV Drug Resistance. Whistler, British Columbia, July 3-6, 1996. Dean L. Winslow, M.D. Curriculum Vitae - Page 16 61. Patick AK, Duran M, Cao Y, Ho T, Pei Z, Keler MR, Anderson R, Winslow DL, Markowitz M. Genotypic and Phenotypic Characterization of HIV-1 Variants Isolated from in vitro Selection Studies and from Patients Treated with the Protease Inhibitor, Nelfinavir. Fifth International Workshop on HIV Drug Resistance. Whistler, British Columbia, July 3-6, 1996. 62. Anton ED, Baker D, Logue K, Scarnati H, Cordova B, Winslow DL, Bacheler LT. Influence of gag Sequences on the Replicative Capacity of HIV-1 Protease Mutants. Fifth International Workshop on HIV Drug Resistance. Whistler, British Columbia, July 3-6, 1996. 63. Saravolatz L, Collins G, Hodges J, Winslow DL, and the Community Programs for Clinical Research on AIDS 007 Protocol Team. A Randomized Comparative Trial of ZDV versus ZDV plus ddI versus ZDV plus ddC in Persons with CD4 Cell Counts of <200/mm3. XI International Conference on AIDS. Vancouver, British Columbia, July 6-10, 1996. 64. Mayers DL, Saravolatz L, Winslow DL, Jagodzinski L, Collins G, Hodges D, Pettinelli C, Weislow O, Stein D. Viral burden measurements in CPCRA 007. XI International Conference on AIDS, Vancouver, British Columbia, July 6-10, 1996. 65. Donovan R, Mayers D, Bush C, Jagodzinski L, Weislow O, Baxa D, Winslow DL, Saravolatz L. Prediction of Disease Progression in CPCRA 007: The Role of Unintegrated HIV DNA. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Louisiana, September 15-18, 1996. 66. Markowitz M, Winslow DL, Cao Y, Hurley A, O’Donovan R, Anderson B, Smiley L, Keller A, Johnson P, Johnson D, Ho D. Triple Therapy with Nelfinavir (VIRACEPT) in Combination with AZT and 3TC in 12 Antiretroviral-Naive Subjects Chronically Infected with HIV-1. Tenth International Conference on Antiviral Research. Atlanta, Georgia, April 6-11, 1997. 67. Lawrence J, Schapiro J, Pesano R, Winters M, Cain P, Winslow DL, Merigan T. Clinical Response and Genotypic Resistance Patterns of Sequential Therapy with Nelfinavir Followed by Indinavir plus Nevirapine in Saquinavir/RTI Experienced Patients. International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication. St. Petersburg, Florida, June 25-28, 1997. 68. Henry K, Kane E, Melroe H, Simpson J, Patick A, Winslow DL. Experience with a Ritonavir/Saquinavir Based Regimen for the Treatment of HIV Infection in Subjects Developing Increased Viral Loads While Receiving Nelfinavir. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Ontario, September 28-October 1, 1997. 69. Becker MI, Wilson D, Yuen N, Clendeninn N, Mattingly M, Winslow DL. An Expanded Access Program With VIRACEPT (Nelfinavir Meslate). 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Ontario, September 28-October 1, 1997. 70. Riddler S, Havlir D, Squires K, Winslow DL, Kerr B, Nguyen BY, Yeh K, Hawe L, Zhong L, Deutsch P, Saah A. Co-administration of Indinavir (IDV) and Nelfinavir (NFV) Without RTI’s in a Twice Daily Regimen: Preliminary Safety, Pharmacokinetic and Anti-viral Activity Results. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Ontario, September 28-October 1, 1997. 71. Lawrence J, Schapiro J, Winters M, Montoya J, Zolopa A, Pesano R, Winslow DL, Merigan TC. Salvage Therapy with Indinavir plus Nevirapine in Patients Previously Treated With Two Other Protease Inhibitors and Multiple Reverse Transcriptase Inhibitors. 37th ICAAC, Toronto, Ontario, September 28October 1, 1997. 72. Winslow DL. HIV Resistance Relational Databases and the Intercompany Collaboration for AIDS Drug Development. Antiviral Therapy: Targets, Resistance, Strategies to Minimize Resistance. Lake Tahoe, CA, January 19-24, 1998. Dean L. Winslow, M.D. Curriculum Vitae - Page 17 73. Lawrence J, Schapiro J, Winters M, Montoya J, Zolopa A, Pesano R, Winslow DL, Merigan TC. Salvage Therapy with Indinavir plus Nevirapine in Patients Previously Treated With Two Other Protease Inhibitors and Multiple Reverse Transcriptase Inhibitors. 5th Conference on Retroviruses and Opportunistic Infections. Chicago, Illinois, February 1-5, 1998. 74. Havlir DV, Riddler S, Squires K, Winslow DL, Kerr B, Nguyen BY, Yeh K, Howe L, Zhong L, Deutsch P, Saah A. Co-administration of Indinavir and Nelfinavir in a Twice Daily Regimen: Preliminary Safety, Pharmacokinetic and Antiviral Activity Results. 5th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, February 1-5, 1998. 75. Winslow D, Myers A, Blick G, Shepp D, Simon G, Coakley D, Lee J. A phase II randomized open label study of adefovir dipivoxil (Preveon(tm), ADV) in combinations with indinavir (IDV), zidovudine (ZDV), lamivudine (3TC), and stavudine (D4T) in therapy naive HIV-infected patients. Abstract #22371, presented at the 12th World AIDS Conference, Geneva, Switzerland, June 28-July 3, 1998. 76. Barriere S, Winslow DL, Coakley D, Rooney J. Safety of adefovir dipivoxil in the treatment of HIV infection. Abstract #12386, presented at the 12th World AIDS Conference, Geneva, Switzerland, June 28July 3, 1998. 77. Meyers RA, Blick G, Shepp D, Simon G, Gallant J, Peake S, Thompson M, Coakley D, Lee J, Bruce J, Rosen A, Winslow DL. Randomized Study of Adefovir Dipivoxil (ADV) in Combination with Indinavir (IDV) and Reverse Transcriptase Inhibitors for Treatment-Naive HIV-infected Patients. 38th Interscience Conference in Antimicrobial Agents and Chemotherapy, San Diego, CA, September 24-27, 1998. 78. Kahn J, Lagakos S, Weng D, Winslow DL, Hardy D, Beall G, Cooper R, Murphy R, Coakley D, Wulfsohn M, Jaffe HS. A Multi-Center, Randomized, Double-Blind Placebo Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil (ADV) when added to Standard Antiretroviral Therapy (ART). 4th International Congress on Drug Therapy in HIV Infection, Glasgow, Scotland, November 8-12, 1998. 79. Thompson M, Roberts A, Wheat LJ, Zurlo J, Gallant J, Peake S, Peterson D, Coakley D, Hill P, Bruce J, Rosen A, Winslow DL. Randomized Study for Adefovir Dipivoxil in Combination with Indinavir and Reverse Transcriptase Inhibitors for Treatment-Naïve HIV-infected Patients. 4th International Congress on Drug Therapy in HIV Infection, Glasgow, Scotland, November 8-12, 1998. 80. Miller MD, Coleman RL, Wiznia A, Winslow DL, Coakley DF. Durable HIV RNA Reductions Seen in Pediatric Patients with Pre-Existing Nucleoside Resistance Mutations Treated with Adefovir Dipivoxil, Nelfinavir and Additional Nucleoside RT Inhibitors. Second International Workshop on Salvage Therapy for HIV Infection, Toronto, Canada, May 19-21, 1999. 81. Winters MA, Lawrence J, Winslow DL, Rath B, Merigan TC. A Pilot Study of Salvage Therapy with Saquinavir plus Nelfinavir plus Adefovir Dipivoxil plus Nevirapine in HIV-1-Infected Individuals who failed Indinavir plus 2 or more Reverse Transcriptase Inhibitors. 3 rd International Workshop on HIV Resistance and Treatment Strategies, San Diego, CA, June 23-26, 1999. 82. Miller MD, Naeger LK, Margot NA, Mulato AS, Lamy PD, Cihlar T, Wulfsohn MS, Coakley DF, Winslow DL. Genotypic Changes in RT and Protease in PI-Naïve Patients Treated with Adefovir Dipivoxil (ADV) at Two Dose Levels in Combination with other NRTIs and PIs. 3 rd International Workshop on HIV Resistance and Treatment Strategies, San Diego, CA, June 23-26, 1999. 83. Gallant J, Beal J, Myers R, Peterson D, Roberts A, Thompson M, Rosen A, Bruce J, Coleman R, Coakley D, Miller M, Winslow DL. Randomized, Double Blind, Study of Adefovir Dipivoxil (ADV) at Two Dose Levels in Combination with Nucleoside Reverse Transcriptase Inhibitors (NRTI) and Protease Inhibitors (PI) for NRTI-Experienced, PI-Naïve Patients. ICAAC – 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 26-29, 1999. 84. Kuritzkes DR, Grant R, Feorino P, Griswold M, Baxter J, Hoover M, Young R, Morgan G, Day S, Winslow DL. Performance Characteristics of the TRUGENE HIV-1 Genotyping Kit and OpenGene DNA Dean L. Winslow, M.D. Curriculum Vitae - Page 18 Sequencing System. 9th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, February 2428, 2002. 85. Grant RM, Lloyd RM, D’Aquila R, Sullivan JL, Swanstrom R, Johnson V, Mellors J, Holodniy M, Reid C, Morgan G, Winslow DL. Reproducibility and Accuracy of a Novel Kit-based Genotyping Assay for HIV1 Drug Resistance. 9th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, February 2428, 2002. 86. Reid CL, Winslow DL, Smith K, Baxter JD, Brun-Vezinet F, Clotet B, Grant RM, Loveday C, Merigan TC, O’Brien W, Wainberg MA, Schapiro JM. Procedure for Sustaining a Rules Based Drug Resistance Interpretation Algorithm. 18th Clinical Virology Symposium, Clearwater, FL, April 28- May 1, 2002. 87. Larder B, DeGruttola V, Hammer S, Harrigan R, Wegner S, Winslow DL, Zazzi M. The International HIV resistance response database initiative: a new global collaborative approach to relating viral genotype and treatment to clinical outcome. 11th International Workshop on HIV Drug Resistance and Treatment Strategies, Seville, Spain, July 2-6, 2002. 88. Reid CL, Bassett R, Day S, Larder B, DeGruttola V, Winslow D. A Dynamic Rules-Based Interpretation System Derived by an Expert Panel is Predictive of Virologic Failure. 11 th International Workshop on HIV Drug Resistance and Treatment Strategies, Seville, Spain, July 2-6, 2002. 89. Wang D, DeGruttola D, Hammer S, Harrigan R, Larder B, Wegner S, Winslow DL, Zazzi M. A collaborative HIV resistance response database initiative: predicting virological response using neural network models. 11th International Workshop on HIV Drug Resistance and Treatment Strategies, Seville, Spain, July 2-6, 2002. 90. Zeitler N, Schmidt B, Kom K, Keulen W, Boucher CAB, Beerenwinkel N, Selbig J, Vandamme A-M, Winslow DL, Shafer R, Schapiro JM, Boulmé R, Schmit JC, Walter H. Determination of the optimal cut-offs for predicting the phenotype of nine different HIV drug resistance algorithms. 11 th International Workshop on HIV Drug Resistance and Treatment Strategies, Seville, Spain, July 2-6, 2002. 91. Reid CL, Winslow DL, Smith K, Baxter JD, Brun-Vezinet F, Clotet B, Grant RM, Loveday C, Merigan TC, O’Brien W, Wainberg MA, Schapiro JM. HIV-1 Drug Resistance Genotype Interpretation: How to Establish and Maintain an Algorithm. 14th International AIDS Conference, Barcelona, Spain, July 7-12, 2002. 92. Winslow DL. Healthcare Crisis in Iraq. Stanford Global Health Symposium. Stanford University. Stanford, CA, May 20, 2008. Published Articles (64) 1. Winslow DL, Taylor WA, Holloway WF. Legionnaires' Disease. Del Med J 1979;51:133-141. 2. Winslow DL, Scott EG, Holloway WJ. Listeria Sepsis. - In Holloway WJ (ed), Infectious Disease Reviews, Volume VI, Futura Publishing Company, Mount Kisco, New York 1980;pp. 187-215. 3. Castillo LE, Winslow DL, Pankey GA. Wound Infection and Sepsis Due to Vibrio vulnificus. Am J Trop Med Hyg 1981;30:844-848. 4. Winslow DL, Pankey GA. In Vitro Activity of Antimicrobial Combinations Containing Rifampin or Trimethoprim Against Listeria monocytogenes. In Baquero, F (ed) Proceedings of the 8th International Symposium on the Problems of Listeriosis. Madrid, Spain September 22-27, 1981. 5. Winslow DL, Pankey GA. In Vitro Activities of Trimethoprim and Sulfamethoxazole Against Listeria monocytogenes. Antimicrobial Agents and Chemotherapy 1982;22:51-54. Dean L. Winslow, M.D. Curriculum Vitae - Page 19 6. Winslow DL, Pankey GA. Development of Flavobacterium meningosepticum Meningitis on Erythromycin Therapy - Successful Therapy with Rifampin. Delaware Medical Journal 1982;54:575-579. 7. Winslow DL, Damme J, Dieckman E. Delayed Bactericidal Activity of Beta-lactam Antibiotics Against Listeria monocytogenes - Antagonism of Chloramphenicol and Rifampin. Antimicrobial Agents and Chemotherapy 1983;23:555-558. 8. Steele MB, Holloway WJ, Winslow DL. In Vitro Activities of Various B-lactams Against Pseudomonas Species. Proceedings of the 13th International Congress of Chemotherapy. Vienna, Austria 1983. 9. Winslow DL, Holloway WF, Reinhardt JF. Treatment of Gram-negative Bacteremia with Intravenous Trimethoprim Sulfamethoxazole. Proceedings of the 13th International Congress of Chemotherapy. Vienna, Austria 1983. 10. Holloway WJ, Winslow DL. Cefotetan in Complicated Urinary Tract Infections. Proceedings of the 13th International Congress of Chemotherapy. Vienna, Austria 1983. 11. Bentsen C, Winslow DL. Staphylococcus epidermidis Bacteremia: A Case Report. Clinical Applications Briefs for DuPont Isolator October 1983. 12. Winslow DL, Steele MB. Listeria Bacteremia and Peritonitis Associated with a Peritoneovenous Shunt: Successful Treatment with Trimethoprim and sulfamethoxazole. Journal of Infectious Diseases 1984;149:820. 13. Winslow DL, Jones R. Severe Cellulitis due to Aeromonas hydrophila Following Immersion Injury. Delaware Medical Journal 1984;56:361-362. 14. Winslow DL. Antibiotic Selection in the Neutropenic Patient. Delaware Medical Journal 1984;56:413415. 15. Winslow DL. Infections Due to Cryptococcus neoformans. Delaware Medical Journal 1985;57:173175. 16. Winslow DL, Holloway WJ. A Randomized Study Comparing Timentin with Piperacillin and Tobramycin Treatment of Septicemia and Lower Respiratory Infections. Proceedings of the 14th International Congress of Chemotherapy. Kyoto, Japan 1985. 17. Winslow DL, Taylor WA. AIDS in Delaware, Experience with Opportunistic Infections and Malignancies in 26 Patients. Delaware Medical Journal 1986;58:383-395. 18. Tribe DE, Reed DL, Lindell P, Kenealy WR, Ferguson BQ, Cybulski R, Winslow DL, Waselefsky DM, Petteway SR. Antibodies Reactive with Human Immunodeficiency Virus (HIV) gag antigens (gag Reactive Only) are a Major Cause of Enzyme-linked Immunosorbent Assay Reactivity in a Blood Donor Population. Journal of Clinical Microbiology 1988;26:641-647. 19. Winslow DL. The Medical Center of Delaware Infectious Disease Clinic. Delaware Medical Journal 1989;61:25-27. 20. Holloway WJ, Winslow DL, Reinhardt JF. Cefmetazole Treatment of Intra-abdominal Infection. Journal of Antimicrobial Chemotherapy 1989;23(Suppl.D):47-54. 21. Winslow DL. HIV Update. Delaware Medical Journal 1989;61:229-230. 22. Reinhardt JF, Bacon AE, Winslow DL, Holloway WJ. Brief Report: Ciprofloxacin versus Ceftazidime in Serious Infections. American Journal of Medicine 1989;87(5A):181-182. Dean L. Winslow, M.D. Curriculum Vitae - Page 20 23. Reagan KJ, Lile CC, Book GW, Devash Y, Winslow DL, Bincsik A. The Use of Urine for HIV-1 Antibody Screening. Lancet 1990;335:358-359. 24. Bach MC, Howell DA, Valenti AJ, Smith TJ, Winslow DL. Aphthous Ulcerations of the Gastrointestinal Tract in Patients with the Acquired Immunodeficiency Syndrome (AIDS). Annals of Internal Medicine 1990;112:465-467. 25. Winslow DL. Update on Antiretroviral Therapy. Delaware Medical Journal 1990;62:1386-1387. 26. Emmons W, Reichwein B, Winslow DL. Cavitary Pneumonia and Recurrent Bacteremia Due to Rhodococcus equi in a Patient with AIDS: Case Report and Review of the Literature. Reviews of Infectious Diseases 1991;13:91-96. 27. Whitney LW, Winslow DL. Informed Consent for Transfusion. Delaware Medical Journal 1993;65:39. 28. Otto MJ, Garber S, Winslow DL, Reid CD, Aldrich P, Jadhav PK, Patterson CE, Hodge CN, Cheng, YSe. In Vitro Isolation and Identification of HIV Variants with Reduced Sensitivity to C-2 Symmetrical Inhibitors of HIV-1 Protease. Proc. Natl. Acad. Sci. USA 1993;90:7543-7547. 29. Otto MJ, Reid CD, Garber D, Lam P, Scarnati H, Bacheler LT, Rayner MM, Winslow DL. The In Vitro Anti-HIV Activity of DMP 323, A Novel HIV Protease Inhibitor. Antimicrobial Agents and Chemotherapy 1993;37:2606-2611. 30. Jacobson MA, Besch CL, Child C, Hafner R, Matts JP, Muth K, Wentworth DN, Neaton JD, Abrams D, Rimland D, Perez G, Grant IH, Saravolatz LD, Brown LS, Deyton L. The Community Programs for Clinical Research on AIDS: Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized Trial. Journal of Infectious Diseases 1994;169:384-394. (co-author listed in appendix) 31. Mayers DL, Japour AJ, Arduino J-M, Hammer S, Reichman R, Wagner KF, Chung R, Lane J, Crumpacker CS, McLeod G, Beckett LA, Roberts CR, Winslow DLWinslow DL, Burke D, and the RV43 Study Group. Dideoxynucleoside Resistance Emerges with Prolonged Zidovudine Monotherapy. Antimicrobial Agents and Chemotherapy 1994;38:307-314. 32. Winslow DL, Mayers D, Scarnati H, Lane J, Otto MJ. In Vitro Susceptibility of Clinical Isolates of HIV-1 to DMP 323, A Non-Peptidyl HIV Protease Inhibitor. AIDS 1994;8:753-756. 33. Winslow DL, Anton ED, Horlick RA, Zagursky RJ, Tritch R, Scarnati H, Ackerman K, Bacheler LT. Variations of Amino Acids in the Substrate Binding Region of HIV-1 Protease Confer Reduced Sensitivity to Structurally Dissimilar HIV Protease Inhibitors. (Manuscript Submitted). 34. Melnick SL, Sherer R, Louis TA,…, Winslow DL, et al. Survival and disease progression according to gender of patients with HIV infection. JAMA 1994; 272: 1915-1921. 35. Winslow DL, Stack S, King R, Scarnati H, Otto MJ. Limited Sequence Diversity of the HIV-1 Protease Gene from Clinical Isolates and In Vitro Susceptibility to HIV Protease Inhibitors. AIDS Research and Human Retroviruses 1995;11:107-113. 36. King RW, Winslow DL, Garber S, Scarnati H, Stack S, Otto MJ. Identification of a Clinical Isolate of HIV-1 from Northern Thailand with a Naturally Occurring Isoleucine at Position 82 of the Protease. Antiviral Research 1995;28:13-24. 37. King RW, Garber S, Winslow DL, Reid C, Bacheler LT, Anton E, Otto MJ. Multiple Mutations in the Human Immunodeficiency Virus Protease Gene are Responsible for Decreased Susceptibility to Protease Inhibitors. Antiviral Chemistry and Chemotherapy 1995;6: 80-88. Dean L. Winslow, M.D. Curriculum Vitae - Page 21 38. Winslow DL, Steele-Moore L. Ventriculoperitoneal Shunt Infection Due to Listeria monocytogenes. Clinical Infectious Diseases 1995;20:1437. 39. Jacobsen H, Yasargill K, Winslow DL, Craig JC, Krohn A, Duncan IB, Mous J. Characterization of Human Immunodeficiency Virus Type 1 Mutants with Decreased Sensitivity to Proteinase Inhibitor Ro318959. Virology 1995;206:527-534. 40. Winslow DL, Otto MJ. HIV Protease Inhibitors. AIDS 1995;9(Suppl. A):S183-S192. 41. Winslow DL, Anton ED, Horlick RA, Zagursky RJ, Tritch RJ, Scarnati H, Ackerman K, Bacheler LT. Construction of Infectious Molecular Clones of HIV-1 Containing Defined Mutations in the Protease Gene. Biochemical and Biophysical Research Communications 1994;205:1651-1657. 42. Melnick SL, Sherer R, Louis TA, Hillman D, Rodriguez EM, Lackman C, Capps L, Brown LS, Carlyn M, Korvick J, Deyton L, Terry Beirn Community Programs for Clinical Research on AIDS. Survival and Disease Progression According to Gender of Patients with HIV Infection. JAMA 1994;272:1915-1921. (coauthor listed in appendix) 43. Fleming TR, Neaton JD, Goldman A, DeMets DL, Launer C, Korvick J, Abrams D, and the Terry Beirn Community Programs for Clinical Research on AIDS. Insights from monitoring the CPCRA Didanosine/Zalcitabine Trial. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10 (Suppl 2) 9-18, 1995. (co-author listed in appendix) 44. Winslow DL. The United States Strategy of the Rolling Thunder Air Campaign During the Vietnam War- An Evaluation. Air War College Research Paper. Maxwell AFB, AL, 1995. 45. Saravolatz L, Winslow D, Collins G, Hodges J, et al, and the Terry Beirn Community Programs for Clinical Research on AIDS 007 Protocol Team. A Randomized Comparative Trial of zidovudine versus zidovudine plus didanosine versus zidovudine plus zalcitabine in Persons with CD 4 Cell Counts less than 200/mm3. New England Journal Of Medicine 1996;335:1099 – 1106. 46. Winslow DL, Garber S, Reid C, Scarnati H, Baker D, Rayner MM, Anton ED. Selection Conditions Affect the Evolution of Specific Mutations in the Reverse Transcriptase Gene Associated with Resistance to DMP 266. AIDS 1996;10:1205 - 1209. 47. Hodge CN, Aldrich PE, Bacheler LT, Chang CH, Eyermann CJ, Garber S, Grubb M, Jackson DA, Jadhav PK, Korant B, Lam PYS, Maurin MB, Meek JL, Otto MJ, Rayner MM, Reid C, Sharpe TR, Shum L, Winslow DL, Erickson-Viitanen S. Improved cyclic urea inhibitors of the HIV-1 protease:” synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450. Chemistry and Biology 1996;3:301-314. 48. Lam PY, Ru Y, Jadhav PK, Aldrich PE, DeLucca GV, Eyermann CJ, Chang CH, Emmett G, Holler ER, Daneker WF, Li L, Confalone PN, McHugh RJ, Han Q, Li R, Markwalder JA, Seitz SP, Sharpe TR, Bacheler LT, Rayner MM, Klabe RM, Shum L, Winslow DL, Kornhauser DM, Hodge CN, et al. Cyclic Urea Protease Inhibitors: Synthesis, Conformational Analysis, P2/P2’ Structure-Activity Relationship, and Molecular Recognition of Cyclic Ureas. Journal of Medicinal Chemistry 1996;39:3514-3525. 49. HIV Trialists’ Collaborative. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. Lancet 1999; 353: 2014-2025. 50. Lawrence J, Shapiro JM, Winters MA, Montoya JG, Zolopa AR, Pesano R, Efron B, Winslow DL, Merigan TC. Clinical Resistance Patterns and Responses to Two Sequential Protease Inhibitor Regimens in Saquinavir/Reverse Transcriptase Inhibitor Experienced Persons. Journal of Infectious Diseases 1999;179:1356-1364. Dean L. Winslow, M.D. Curriculum Vitae - Page 22 51. Kahn J, Lagakos S, Wulfsohn M, Cherng D, Miller M, Cherrington J, Hardy D, Beall G, Cooper R, Murphy R, Basgoz N, Ng E, Deeks S, Winslow DL, Toole J, Coakley D. Efficacy and Safety of Adefovir Dipivoxil with Antiretroviral Therapy: A Randomized Controlled Trial. Journal of the American Medical Association 1999;282:2305-2312. 52. Grant RM, Lloyd RM, Johnson V, Mellors J, Sullivan JL, Swanstrom R, D’Aquila R, Holodniy M, Reid C, Morgan G, Winslow DL. Reproducibility and Accuracy of a Novel Genotyping Assay for HIV-1 Drug Resistance. Journal of Clincal Microbiology 2003;41:1586-1593. 53. Kuritzkes DR, Grant RM, Feorino P, Griswold M, Hoover M, Young R, Day S, Lloyd R, Reid C, Morgan G, Winslow DL. Performance Characteristics of the TRUGENE HIV-1 Genotyping Kit and OpenGene DNA Sequencing System. Journal of Clinical Microbiology 2003;41:1594-1599. 54. Hoover ML, Wentworth DN, Neaton JD, Morgan G, Winslow DL, Baxter JD. A Blinded Comparison of the TRUGENE HIV-1 Genotyping Kit and a Homebrew Assay for HIV-1 Resistance Mutations in the GART Study (CPCRA 046). AIDS (submitted). 55. Ravela J, Betts BJ, Brun-Vezinet F, Vandamme A-M, Descamps D, Van Laethem K, Smith K, Schapiro JM, Winslow DL, Reid C, Shafer R. HIV-1 Protease and Reverse Transcriptase Mutation Patterns Responsible for Discordance Between Genotypic Drug Resistance Interpretation Algorithms. Journal of AIDS Research and Human Retrovirology 2003;33:8-14. 56. Winslow DL. Wind, Rain, Flooding, and Fear: Coordinating Military Public Health in the Aftermath of Hurricane Katrina. Clinical Infectious Diseases 2005;41:1759-1763. 57. Winslow DL. Failure of American Foreign Policy: The Bush Administration and the Israeli/Palestinian Conflict. Air War College Research Paper 2006. Maxwell AFB, AL 58. Winslow DL. On Being a Doctor—Treating the Enemy. Annals of Internal Medicine 2007;147:278279. 59. Leung JM, O’Brien JG, Wong HK, Winslow DL. Efavirenz-Induced Hypersensitivity Reaction Manifesting in Rash and Hepatitis in a Latino Male. Annals of Pharmacotherapy 2008;42: 425-429. 60. Winslow DL. Replication Capacity of HIV-1 in the Presence of Resistance-associated Substitutions in Protease. Clinical Infectious Diseases 2009; 49: 165-166. 61. Van Horn GT, Goodrich A, Winslow DL. Gross Hematuria in a Young Iraqi Man. Clinical Infectious Diseases 2010; 50: 1198-1199. 62. Lindfelt T, O’Brien J., Song JC, Patel R, Winslow DL. Efavirenz Plasma Concentrations and Cytochrome 2B6 polymorphisms. Annals of Pharmacotherapy 2010; 44: 1572-1578. 63. Shelby S, Ho C, Brooks E, Winslow DL, Kamal A, Doorley S. HIV and the Homeless: The Effect of Housing Status on HIV Disease Progression and Healthcare Access. J Gen Int Med 2011; 26: S52-S53. 64. Detels RW, Winslow DL. Treatment as Prevention: Some Additional Thoughts (editorial). AIDS 2012; 26: 519-520. INVITED LECTURES: Years 1989 to 1999 01/09/89 "Clinical Aspects of HIV Disease" DuPont AIDS Symposium, Wilmington, DE. Dean L. Winslow, M.D. Curriculum Vitae - Page 23 01/17/89 "Infections Due to Listeria Monocytogenes" Infectious Disease Section Conference, Medical Center of Delaware, Newark, DE. 02/17/89 "AIDS and HIV Infection" Red Clay School District Nurses, Wilmington, DE. 04/11/89 "Management of HIV Disease" Medical Grand Rounds, Medical Center of Delaware, Wilmington, DE. 04/17/89 "Immunologic Mechanisms and Host Resistance to Infection" Family Practice Conference, Medical Center of Delaware, Wilmington, DE. 04/26/89 "Management of Complications of HIV Infection" Infectious Disease Section Conference, Medical Center of Delaware, Newark, DE. 05/05/89 "The Human Immunodeficiency Virus - Virology and Immunopathogenesis" College of Life Sciences, University of Delaware, Newark, DE. 06/20/89 "AIDS in Delaware" Family Services of Delaware, Wilmington, DE. 06/24/89 "Infection Management in the Emergency Department" American Academy of Emergency Physicians, Atlantic City, NJ. 07/12/89 "Central Nervous System Infections" Neurology Section Conference, Medical Center of Delaware, Newark, DE. 09/20/89 "Laboratory Diagnosis in Infectious Disease" Infectious Diseases Section Conference, Medical Center of Delaware, Newark, DE. 09/21/89 "AIDS - Current Research" DuPont Company Occupational Health Physicians, Wilmington, DE. 10/19/89 "Current Treatment and Research in Rheumatoid Arthritis" Delaware Chapter, Arthritis Foundation, Wilmington, DE. 10/24/89 "Blood-borne Pathogens" DuPont Virology Research Review, Wilmington, DE. 11/01/89 "Virology and Immunopathogenesis of HIV Infection" Delaware Society of Pathologists, Wilmington, DE. 01/04/90 "Current Research on HIV" Leadership Delaware, Buena Vista, New Castle, DE. 01/18/90 "Management of HIV Disease" Medical Grand Rounds, Medical Center of Delaware, Newark, DE. 01/23/90 "Update on HIV Infection" Medical Grand Rounds, Kent General Hospital, Dover, DE. 02/16/90 "AIDS in Delaware" Rotary Club, Wilmington, DE. 03/12/90 "Medical Management of AIDS" Medical/Legal Symposium, University of Delaware, Newark, DE. Dean L. Winslow, M.D. Curriculum Vitae - Page 24 03/13/90 "AIDS Update" Clinical Research Staff, DuPont Pharmaceutical Company, Wilmington, DE. 03/14/90 "Antiviral Therapy" Infectious Disease Section Conference, Medical Center of Delaware, Newark, DE. 04/11/90 "Immunopathogenesis of HIV" Keynote Address, Centers for Disease Control/Association of State and Territorial Public Health Laboratory Directors, Baltimore, MD. 06/05/90 "AIDS - The Disease and Current Treatment" DuPont Chambers Works, Deepwater, NJ. 08/28/90 "Host Defense Against Infection" DuPont Molecular Biology Seminar Series, Experimental Station, Wilmington, DE. 10/12/90 "AIDS in the Emergency Department" Department of Emergency Medicine Conference, Medical Center of Delaware, Newark, DE. 12/06/90 "HIV Treatment Update" DuPont Central Research Meeting, Wilmington, DE. 12/12/90 "Host Defenses Against Infection" Infectious Disease Section Conference, Medical Center of Delaware, Newark, DE. 02/27/91 "Current Research on HIV" DuPont Central Research, Experimental Station, Wilmington, DE. 03/27/91 "Antiviral Therapy" Department of Life and Health Sciences, University of Delaware, Newark, DE. 04/30/91 "Epstein Barr Virus Infections" Family Practice Residents Conference, St. Francis Hospital, Wilmington, DE. 05/08/91 "HIV and AIDS - Laboratory Diagnosis and Immunopathogenesis" Keynote Address, Centers for Disease Control/Association of State and Territorial Public Health Laboratory Directors, Princeton, NJ. 09/12/91 "Central Nervous System Manifestations of HIV" Neurology Section Conference, Medical Center of Delaware, Newark, DE. 09/12/91 "Unmet Medical Needs in Treatment of Herpes Virus Infections" DuPont Merck Virology Research, Experimental Station, Wilmington, DE. 09/30/91 "HIV and the Emergency Department" Department of Emergency Medicine, Medical Center of Delaware, Newark, DE. 10/23/91 "Infections Due to Listeria monocytogenes" Infectious Disease Section Conference, Medical Center of Delaware, Newark, DE. 01/30/92 "Resistance to Antiviral Agents" Medical Grand Rounds, Medical Center of Delaware, Newark, DE. Dean L. Winslow, M.D. Curriculum Vitae - Page 25 03/19/92 "Infectious Diseases" Visiting Nurses of Delaware, New Castle, DE. 04/21/92 "HIV Infection" DuPont Fibers, Experimental Station, Wilmington, DE. 05/01/92 "Antiretroviral Therapy" Medical Grand Rounds, Geissinger Medical Center, Danville, PA. 06/23/92 "Blood-borne Pathogens" DuPont Merck Occupational Health and Safety, Experimental Station, Wilmington, DE. 07/16/92 "Current Research in HIV Infection" Medical Staff Conference, Langley Air Force Base, VA. 09/16/92 "Nuts and Bolts of Molecular Biology" Infectious Disease Section Conference, Medical Center of Delaware, Newark, DE. 09/21/92 "Mechanisms of Resistance to Antiretroviral Agents" DuPont Molecular Biology Seminar Series, Experimental Station, Wilmington, DE. 10/06/92 "HIV and AIDS" Critical Care Nursing Course, Medical Center of Delaware, Newark, DE. 10/06/92 "AIDS in Delaware" First Presbyterian Church, Wilmington, DE. 10/13/92 "Current Treatment of HIV Disease" Delaware Conference on AIDS, Delaware State College, Dover, DE. 01/06/93 "Viral Diagnostic Testing" Blood Bank of Delaware Medical Advisory Committee, Dover, DE. 01/11/93 "AIDS Research at DuPont Merck" DuPont Fibers Seminar Series, Kinston, NC. 01/19/93 "Diagnosis and Treatment of HIV Infection" DuPont Stine Laboratory Seminar Series, Newark, DE. 01/27/93 "Antiviral Resistance" Infectious Disease Section Conference, Medical Center of Delaware, Newark, DE. 05/07/93 "New Concepts in Antiretroviral Therapy" Infectious Disease Review Course, Delaware Academy of Medicine, Wilmington, DE. 05/13/93 "AIDS in Delaware" New Castle County Public School Nurses, Wilmington, DE. 06/24/93 "Update on HIV Infection" Dean L. Winslow, M.D. Curriculum Vitae - Page 26 DuPont Occupational Health Physicians and Nurses, Stine Laboratory, Newark, DE. 07/07/93 "Laboratory Diagnosis in Infectious Diseases" Infectious Diseases Section Conference, Medical Center of Delaware, Newark, DE. 07/19/93 "Treatment of HIV Infection" DuPont Merck New Product Planning, Wilmington, DE. 07/29/93 "AIDS in Delaware and the Safety of the Blood Supply" Rotary Club, Wilmington, DE. 08/25/93 "Antiretroviral Therapy" DuPont Merck Science Commitment Conference, University of Delaware, Newark, DE. 10/20/93 "AIDS in Delaware" Colonial School District PTA, New Castle, DE. 11/02/93 "HIV Infection" Blood Bank of Delaware, Newark, DE. 11/16/93 "HIV Infection" Blood Bank of the Eastern Shore, Salisbury, MD. 12/07/93 "Resistance to HIV Protease Inhibitors" Plenary Lecture, AIDS Clinical Trials Group Meeting, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Washington, D.C. 01/12/94 "Infections Due to Listeria monocytogenes" Infectious Diseases Section Conference, Medical Center of Delaware, Newark, DE. 01/26/94 "Central Nervous System Infections" Medical Student Lecture Series, Jefferson Medical College, Philadelphia, PA. 05/09/94 "Resistance to HIV Protease Inhibitors" DuPont Merck Molecular Biology Seminar Series, Experimental Station, Wilmington, DE. 06/02/94 "HIV Protease Inhibitors, A New Class of Antiretroviral Agents" IX Annual Tri-Service Infectious Disease Meeting, Scottsdale, AZ. 06/09/94 "Listeriosis" Medical Grand Rounds, Department of Medicine, Medical Center of Delaware, Newark, DE. 07/06/94 "Clinical Assessment of the HIV-positive Patient" Infectious Disease Section Conference, Medical Center of Delaware, Newark, DE. 07/11/94 "New Concepts in HIV Disease - Pathogenesis and Medical Management" Drexel AIDS Education Institute Conference, Philadelphia, PA. 07/20/94 "New Concepts in Antiretroviral Therapy" Medical Grand Rounds, Henry Ford Hospital, Detroit, MI. Dean L. Winslow, M.D. Curriculum Vitae - Page 27 07/26/94 "DMP450, A Cyclic Urea HIV Protease Inhibitor with Improved Oral Bioavailability" Primary Infection Committee, AIDS Clinical Trials Group. NIAD/NIH, Washington, DC. 10/20/94 "Resistance to HIV Protease Inhibitors" Intercompany Collaboration for AIDS Drug Development. Woodbridge, NJ. 01/19/95 "New Concepts of Pathogenesis of HIV Disease" Staff Conference, 39th Medical Group (USAF), Incirlik AB, Turkey. 02/01/95 "Central Nervous System Infections" Medical Student Lecture Series, Jefferson Medical College, Philadelphia, PA. 03/29/95 "Molecular Biology For Clinicians" Infectious Disease Conference, Medical Center of Delaware, Newark, DE. 04/13/95 "Systemic Fungal Infections" Internal Medicine Resident Lecture Series, Medical Center of Delaware, Newark, DE. 04/28/95 "HIV Infection and AIDS" Lecture to Students, Faculty and Parents, St. Peter's School, New Castle, DE. 07/25/95 "HIV Disease and Antiretroviral Therapy" DuPont Merck Post-doctoral Lecture Series, Wilmington, DE. 09/10/95 "Monitoring the Emergence of Drug Resistance and the Impact of Therapeutic Interventions" FDA Seminar, Fourth Workshop on Viral Resistance, Annapolis, MD. 09/12/95 "Impact of Viral Genetic Background on Observed Viral Phenotype" Fourth Workshop on Viral Resistance, Annapolis, MD. 12/05/95 "DMP 266, a Novel Non-nucleoside Reverse Transcriptase Inhibitor" Pediatric Primary Therapy Committee, AIDS Clinical Trials Group. NIAID/NIH, Washington, DC. 03/15/96 “Nelfinavir, HIV Protease Inhibitor” California Collaborative Treatment Group, University of California, Irvine, Irvine, CA. 05/14/96 “Update on the Use of Protease Inhibitors in the Treatment of HIV Infection” American Foundation for AIDS Research, Boston, MA. 06/11/96 “Nelfinavir, a Novel HIV Protease Inhibitor” International Conference on Protease Inhibitors, Novel Therapeutic Application and Development. San Francisco, CA. 06/22/96 “Nelfinavir, Clinical Experience with a Novel HIV Protease Inhibitor” Drug Approval/Strategy Trial Symposium, Royal Society of Medicine, London, UK. 03/21/97 “Nelfinavir and the Newer Antiretroviral Agents” Infectious Disease Conference, Medical Center of Delaware, Newark, Delaware. 04/17/97 “Nelfinavir and Other HIV Protease Inhibitors in Clinical Practice” Dean L. Winslow, M.D. Curriculum Vitae - Page 28 ACTU Conference, University of Southern California School of Medicine, Los Angeles, CA. 04/24/97 “Structural and Biological Basis for Resistance to HIV Protease Inhibitors” Medical Grand Rounds, Carolinas Medical Center, Charlotte, NC. 05/18/97 “New HIV Protease Inhibitors in Clinical Practice” Infectious Disease Conference, Jackson Memorial Hospital, University of Miami School of Medicine, Miami, FL. 06/05/97 “Structural and Biological Basis for Resistance to HIV Protease Inhibitors” HIV Conference, Atlantic City Medical Center, Atlantic City, NJ. 06/20/97 “Antiretroviral Therapy for HIV Disease” Invited lecture, University of Health Sciences, Kansas City, MO. 08/22/97 “Update on Nelfinavir” HIV Rounds, San Francisco General Hospital AIDS Program (UCSF), San Francisco, CA. 11/05/97 “New Therapies for HIV Treatment” 10th Annual Delaware HIV/STD Conference, Wilmington, DE. 01/09/98 “Adefovir Dipivoxil and its Potential Use in Antiretroviral Intensification Regimens” Military Medical Consortium for AIDS Research, Rockville, MD. 04/18/98 “New Antivirals for Children with HIV/AIDS” Pediatric ACTG Leadership Retreat, San Diego, CA. 06/17/98 “Update on Adefovir Dipivoxil” AIDS Research Consortium of Atlanta, Atlanta, GA. 10/27/98 “HIV Update” Medical Grand Rounds. Venice Bon Secoeur Hospital, Venice, FL. 11/5/98 “Resistance to Antiretroviral Agents in Practice” 11th Annual Delaware HIV/STD Conference, University of Delaware, Newark, DE. 11/6/98 “Adefovir Dipivoxil” HIV Clinical Conference, Massachusetts General Hospital, Boston, MA. 11/10/98 “Adefovir Dipivoxil, Update on Safety and Efficacy” Division of AIDS Medical Conference, NIAID, NIH, Rockville, MD. 01/14/99 “Laboratory Diagnosis of Infectious Diseases” Medical Staff Conference, 24th Medical Group (USAF), Howard AFB, Panama. 02/12/99 “New Therapies for HIV Infection: Reverse Transcriptase Inhibitors” Stanford University, HIV Course, Stanford, CA. Years 2000 to 2015 (154 out of 255 ) 04/26/01 “Antiviral resistance testing—HIV and Hepatitis” California Association of Public Health Laboratory Directors, Newport Beach, CA Dean L. Winslow, M.D. Curriculum Vitae - Page 29 09/25/01 “HIV Resistance Testing” San Francisco Department of Public Health, San Francisco, CA 10/03/01 “HIV Genotypic Resistance Testing” Symposium on HIV Resistance Testing New England AIDS Education and Treatment Consortium, Boston, MA 11/15/01 “HIV Resistance Testing—Genotyping” Agouron/Pfizer GAIN Study Investigator’s Meeting, Scottsdale, AZ 03/14/02 “The TRUGENE HIV-1 Genotyping Kit and OpenGene DNA Sequencing System—The Regulatory Path Taken” 3rd International Antiviral and Vaccine Discovery and Development Summit, Princeton, NJ 09/26/02 “20 Years as a Flight Surgeon” Commencement Address. The United States Air Force School of Aerospace Medicine, Brooks Air Force Base, TX 10/08/02 “HIV Treatment Update and Resistance to Antiretroviral Agents” Iowa HIV/AIDS Conference 2002, Des Moines, IA 12/19/02 “Endogenous Endophthalmitis” Stanford/VA Medicine Conference, Palo Alto, CA 12/23/02 “Infections in the Intensive Care Unit” Stanford/VA ICU Conference, Palo Alto, CA 03/13/03 “Antimicrobial Therapy” Medical Staff Conference, 39th Medical Group, USAF Hospital, Incirlik AB, Turkey 04/17/03 “Diagnosis and Management of Common Infectious Syndromes” Medical Staff Conference, 86th EMEDS, deployed to undisclosed location, Southwest Asia AOR 06/16/03 “HIV Drug Resistance—an Historical Perspective” Research Seminar, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 08/06/03 “Opportunistic Infections in Patients with AIDS” Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 09/15/03 “Antimicrobial Therapy and Management of Common Infections” Medical Staff Conference, 379th EMEDG, Al Udeid Air Base, Qatar 12/12/03 “Antiretroviral Agents and HIV Drug Resistance” Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 04/08/04 “Neutropenic enterocolitis and clostridial bacteremia in a patient with myelodysplastic syndrome” Multidisciplinary Case Conference, Stanford/Palo Alto VA, Palo Alto, CA 04/29/04 “Military Medical Operations in the 21st Century” Medicine Grand Rounds, Stanford University School of Medicine, Stanford, CA Dean L. Winslow, M.D. Curriculum Vitae - Page 30 06/11/04 “War in Iraq” Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 09/28/04 “Sepsis” Clinical Conference, Medical Task Force North, Afghanistan AOR, Camp Stronghold Freedom, Uzbekistan 11/18/04 “A doctor’s experience in Iraq” Infectious Diseases Grand Rounds, Stanford University School of Medicine, Stanford, CA 04/14/05 “HIV-related opportunistic infections” Infectious Diseases Grand Rounds, Stanford University School of Medicine, Stanford, CA 05/12/05 “Staphylococcus aureus pneumonia” Department of Medicine Morbidity and Mortality Conference, Santa Clara Valley Medical Center, San Jose, CA 08/25/05 “HIV pathogenesis and opportunistic infections” Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 11/19/05 “HIV resistance testing in clinical practice” Symposium at Association of Nurses in AIDS Care Annual Meeting, Orlando, FL 02/23/06 “HIV resistance” Department of Medicine/Division of Infectious Diseases Teaching Conference, Santa Clara Valley Medical Center, San Jose, CA 02/28/06 “HIV quantification and resistance testing” St. Raphael’s Medical Center, New Haven, CT 04/26/06 “Infectious Diseases Overview” Clinical Conference, 447th EMEDS, Baghdad, Iraq 10/12/06 “Baghdad ER—a Stanford doctor’s experience in Iraq” Medicine Grand Rounds, Stanford University School of Medicine, Stanford, CA 10/24/06 “Opportunistic infections in patients with HIV” Division of Infectious Diseases teaching conference, Stanford University School of Medicine, Stanford, CA 12/15/06 “HIV-related malignancies” Internal Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 1/4/07 “Bacterial meningitis” Neurosciences Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 1/17/07 “HIV genotyping systems” 10th Bangkok Symposium on HIV Medicine, Bangkok, Thailand 2/1/07 “Brain abscess” Neurosciences Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA Dean L. Winslow, M.D. Curriculum Vitae - Page 31 3/1/07 “A military doctor’s experience in Iraq” Medicine Grand Rounds, Christiana Care, Newark, DE 4/25/07 “HIV drug resistance testing” Medicine Grand Rounds, San Mateo Medical Center, San Mateo, CA 5/4/07 “HIV quantification and antiretroviral drug resistance testing” Division of Infectious Diseases Teaching Conference, University of Texas Southwestern Medical School, Dallas, TX 7/13/07 “Resistance to HIV protease inhibitors, viral fitness, and T-cell apoptosis” Citywide Infectious Diseases Grand Rounds, New Orleans, LA 7/13/07 “Baghdad ER—A military doctor’s experience in Iraq” Medicine Grand Rounds, Ochsner Clinic, New Orleans, LA 8/3/07 “Multiple missed opportunistic infections in an AIDS patient” Medicine Grand Rounds, Morbidity and Mortality Conference, Santa Clara Valley Medical Center, San Jose, CA 9/26/07 “HIV quantitation and resistance testing” Molecular Pathology Symposium, William Beaumont Hospital, Detroit, MI 9/27/07 “Opportunistic infections in HIV” Department of Medicine Teaching Conference, Santa Clara Valley Medical Center, San Jose, CA 10/25/07 “Antiretroviral agents and resistance” Department of Medicine Teaching Conference, Santa Clara Valley Medical Center, San Jose, CA 10/26/07 “Baghdad ER—serving as a military doctor in Iraq” 8th Annual Burn and Wound Symposium, San Jose, CA 11/1/07 “Antiretrovirals—mechanisms of action and resistance” UCSF Positive Care Clinic Teaching Conference, San Francisco, CA 12/20/07 “HIV-related malignancies” Infectious Diseases Grand Rounds, Stanford University School of Medicine, Stanford, CA 2/7/08 “Antiretroviral agents and resistance” Medicine Grand Rounds, Christiana Care, Newark, DE 4/7/08 “HIV treatment and strategies” Infectious Diseases Division Conference, Carolinas Medical Center, Charlotte, NC 4/8/08 “Baghdad ER—an American doctor’s experience in Iraq” Medicine Grand Rounds, Carolinas Medical Center, Charlotte, NC 4/8/08 “HIV quantification and antiretroviral resistance testing” Counsel on HIV-1 Disease Management Using Molecular Techniques, Florida Department of Health, Bureau of Laboratories, Jacksonville, FL 7/10/08 “Management of common infections” Clinical Conference, 447th EMEDS, Baghdad, Iraq Dean L. Winslow, M.D. Curriculum Vitae - Page 32 8/16/08 “Antibiotic therapy of common infections” Grand Rounds, 115th Combat Support Hospital, Forward Operating Base Cropper, Baghdad, Iraq 8/18/08 “Endocrinology,” “Orthopedic considerations,” “Gastroenterology” Iraqi Armed Forces Flight Surgeon Training Course, New Al Muthana Air Base, Baghdad, Iraq 8/19/08 “Dermatology,” “Infectious diseases” Iraqi Armed Forces Flight Surgeon Training Course, New Al Muthana Air Base, Baghdad, Iraq 8/21/08 “Coronary artery disease,” “Tachyarryhthmias,” “Valvular heart disease” Iraqi Armed Forces Flight Surgeon Training Course, New Al Muthana Air Base, Baghdad, Iraq 9/10/08 “A military doctor’s experience in Iraq” Pediatric Grand Rounds, Alfred I. DuPont Hospital for Children/Jefferson Medical College, Wilmington, DE and Philadelphia, PA 10/14/08 “HIV-related malignancies” Infectious Diseases Core Curriculum, Stanford University School of Medicine, Stanford, CA 10/23/08 “Antiretroviral therapy” Department of Medicine teaching conference, Santa Clara Valley Medical Center, San Jose, CA 10/23/08 “Antimicrobial therapy of common pediatric infections” Pediatrics teaching conference, Santa Clara Valley Medical Center, San Jose, CA 1/22/09 “Opportunistic infections” Department of Medicine teaching conference, Santa Clara Valley Medical Center, San Jose, CA 2/26/09 “HIV-related malignancies” Department of Medicine teaching conference, Santa Clara Valley Medical Center 3/25/09 “Baghdad ER—an American military doctor’s experience in Iraq” Pediatric Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 4/23/09 “Mechanisms and management of combat injuries—experience in Operation Iraqi Freedom” Trauma Conference, Department of Surgery, Santa Clara Valley Medical Center, San Jose, CA 5/7/09 “Neurocognitive disorders in HIV infection” Alameda County AIDS Conference, San Leandro, CA 6/8/09 “Antiretroviral agents and mechanisms of resistance” Translational Research Seminar Series, A.I.DuPont Institute/Nemours Children’s Hospital, Wilmington, DE 7/7/09 “Practical aspects of HIV clinical care” Dean L. Winslow, M.D. Curriculum Vitae - Page 33 Infectious Diseases Core Curriculum, Stanford University School of Medicine, Stanford, CA 7/24/09 “Infective endocarditis” Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 9/24/09 “Opportunistic infections in HIV” Internal Medicine Core Curriculum, Santa Clara Valley Medical Center, San Jose, CA 9/28/09 “Baghdad ER—Caring for American Soldiers, Iraqis, Kids, Kurds, and Detainees” Department of Medicine teaching conference, Santa Clara Valley Medical Center, San Jose, CA 9/28/09 “Acute mastoiditis in a toddler” Infectious Diseases Grand Rounds, Stanford University School of Medicine, Stanford, CA 10/15/09 “Antibiotics-- mechanisms of action and resistance” Pediatrics teaching conference, Santa Clara Valley Medical Center, San Jose, CA 10/22/09 “Antiretroviral therapy and resistance” Internal Medicine Core Curriculum, Santa Clara Valley Medical Center, San Jose, CA 11/30/09 “Caring for American Soldiers, Iraqis, Kids, Kurds, and Detainees in a Combat Zone” Science lecture series, United States Antarctic Program, McMurdo Station, Antarctica 12/5/09 “Antibiotics in acute care medicine” McMurdo Hospital, McMurdo Station, Antarctica 12/8/09 “Pandemic influenza” Science lecture series, United States Antarctic Program, McMurdo Station, Antarctica 1/7/10 “Infections due to Haemophilus influenzae” Pediatrics teaching conference, Santa Clara Valley Medical Center, San Jose, CA 1/15/10 “Antarctica and the Heroic Era of Polar Exploration” Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 4/6/10 “HIV drug resistance” Infectious Diseases Teaching Conference, Stanford University School of Medicine, Stanford, CA 4/7/10 “Opportunistic infections in patients with HIV” Translational Research Seminar Series, A.I.DuPont Institute/Nemours Children’s Hospital, Wilmington, DE 4/20/10 “Approach to opportunistic infections in patients with HIV” Internal Medicine Teaching Conference, Stanford University School of Medicine, Stanford, CA 4/22/10 “Childhood exanthems” Pediatric Teaching Conference, Santa Clara Valley Medical Center, San Jose, CA Dean L. Winslow, M.D. Curriculum Vitae - Page 34 5/11/10 “HIV update: How antiretroviral drugs work and what’s new in HIV treatment” HIV Care and Prevention 2010 Conference, Santa Clara, CA 7/20/10 “5 year old boy with CNS coccidioidomycosis and communicating hydrocephalus” Pediatric Infectious Diseases Grand Rounds, Lucille Packard Children’s Hospital, Stanford, CA 7/22/10 “Antarctica and the Heroic Era of Polar Exploration” Medicine Grand Rounds, Christiana Care, Newark, DE 8/18/10 “Baghdad ER—the experience of a U.S. military physician in Iraq” Invited lecture, Marines Memorial Club, San Francisco, CA 8/24/10 “Antiretroviral therapy—mechanisms of action and resistance” Infectious Diseases Teaching Conference, Stanford University School of Medicine, Stanford, CA 8/30/10 “Infective endocarditis” Internal Medicine Teaching Conference, Santa Clara Valley Medical Center, San Jose, CA 9/23/10 “Opportunistic infections in HIV” Internal Medicine Teaching Conference, Santa Clara Valley Medical Center, San Jose, CA 10/13/10 “Antarctica and the heroic era of polar exploration” Pediatric Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 10/14/10 “Antarctica and the heroic era of polar exploration” Infectious Diseases Grand Rounds, Stanford University School of Medicine, Stanford, CA 10/28/10 “Antiretroviral therapy and resistance” Internal Medicine Teaching Conference, Santa Clara Valley Medical Center, San Jose, CA 12/17/10 “Invasive disease due to Clostridium perfringens” Medicine Grand Rounds/Morbidity and Mortality Conference, Santa Clara Valley Medical Center, San Jose, CA 1/3/11 “HIV-related malignancies” Hematology/Oncology Teaching Conference, Santa Clara Valley Medical Center, San Jose, CA 1/6/11 “HIV update” Grand Rounds, St. Louise Regional Hospital, Gilroy, CA 3/4/11 “Varicella in adults” Medicine Grand Rounds/Morbidity and Mortality Conference, Santa Clara Valley Medical Center, San Jose, CA 3/18/11 “Infections in patients with HIV” Emergency Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 3/31/11 “Clinical and immunological manifestations of HIV” Dean L. Winslow, M.D. Curriculum Vitae - Page 35 Invited lecture, Medicine 260 HIV Medicine Course, Stanford University School of Medicine, Stanford, CA 5/24/11 “Ethical issues in treatment of detainees” Grand Rounds, Craig Joint Theater Hospital, Bagram Airfield, Afghanistan 5/31/11 “Antibiotic therapy of common infections.” Grand Rounds, Craig Joint Theater Hospital, Bagram Airfield, Afghanistan 6/27/11 “Infective endocarditis” Internal Medicine Teaching Conference, Santa Clara Valley Medical Center, San Jose, CA 7/7/11 “Clinical manifestations of HIV infection” Medicine Grand Rounds, Christiana Care, Newark, DE 8/26/11 “Bascom Avenue to Bagram Airfield to Baghdad and back again” Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 9/29/11 “Afghanistan and Operation Enduring Freedom” Infectious Diseases Grand Rounds, Stanford University School of Medicine, Stanford, CA 10/4/11 “Antiretroviral therapy—history, mechanisms of action and resistance” Infectious Diseases didactic lecture, Stanford University School of Medicine, Stanford, CA 10/29/11 “Care of Combat Injuries in Afghanistan and Iraq” 11th Annual Trauma Seminar-- Burns and Trauma: Catastrophic Injuries/Innovative Solutions, San Jose, CA 1/20/12 “Afghanistan and Operation Enduring Freedom” Medicine Grand Rounds, Ochsner Clinic and Ochsner Foundation Hospital, New Orleans, LA 2/3/12 “Intracerebral hemorrhage complicating infective endocarditis” Morbidity and Mortality Conference, Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 2/14/12 “Clinical manifestations of HIV infection” Internal Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 2/15/12 “From Bascom Avenue to Bagram Airfield to Baghdad and back again” Medicine Grand Rounds, Stanford University School of Medicine, Stanford, CA 2/28/12 “Malignancies in HIV infection” Internal Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 5/11/12 “From Bascom Avenue to Bagram Airfield to Baghdad and back again” Medicine Grand Rounds, Cedars Sinai Medical Center/UCLA, Los Angeles, CA 6/27/12 “How to do an ID consult and some thoughts on professionalism” Infectious Diseases Fellowship Training Program orientation, Stanford University School of Medicine, Stanford, CA Dean L. Winslow, M.D. Curriculum Vitae - Page 36 7/5/12 “From Bascom Avenue to Bagram Airfield to Baghdad and back again” Grand Rounds, St. Louise Regional Hospital, Gilroy, CA 7/6/12 “Professionalism in Medicine and some thoughts on life” Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 8/15/12 “Military medicine in Afghanistan and Iraq” Pulmonary/Critical Care Medicine Grand Rounds, Cedars Sinai Medical Center/UCLA, Los Angeles, CA 10/2/12 “Antiretroviral therapy—mechanisms of action and resistance” Infectious Diseases Fellowship Training Program core lecture, Stanford University School of Medicine, Stanford, CA 10/9/12 “Beta lactam antibiotics” Infectious Diseases Fellowship Training Program core lecture, Stanford University School of Medicine, Stanford, CA 10/29/12 “Infective endocarditis” Internal Medicine teaching conference, Santa Clara Valley Medical Center, San Jose, CA 11/13/12 “From Bascom Avenue to Bagram Airfield to Baghdad and back again” Medicine Grand Rounds, Carolinas Healthcare System, Charlotte, NC 11/13/12 “Antiretroviral agents- mechanisms of action and resistance” Research Lecture, Carolinas Healthcare System, Charlotte, NC 11/29/12 “Antimicrobial resistance in gram-negative bacilli” Internal Medicine teaching conference, Santa Clara Valley Medical Center, San Jose, CA 12/6/12 “Military medicine in Afghanistan and Iraq” Medicine Grand Rounds, Christiana Healthcare System, Newark, DE 12/14/12 “Antiretroviral agents” Invited lecture, Lucile Packard Children’s Hospital, Stanford, CA 2/19/13 “HIV-related malignancies” Internal Medicine core lecture, Stanford University School of Medicine 2/27/13 “Beta lactam antibiotics” Internal Medicine core lecture, Stanford University School of Medicine 4/19/13 “From Bascom Avenue to Bagram airfield to Baghdad and back again” Emergency Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 4/24/13 “Combat casualty care in Afghanistan and Iraq” Combined Medicine/Surgery/Emergency Medicine Grand Rounds, Newark Beth Israel Hospital, Newark, NJ 7/12/13 “From Bascom Avenue to Bagram airfield to Baghdad and back again” Medicine Grand Rounds, Santa Clara Valley Medical Center, San Jose, CA 8/9/13 “Military medical care in our wars in Afghanistan and Iraq” Dean L. Winslow, M.D. Curriculum Vitae - Page 37 Medicine Grand Rounds, Geisel School of Medicine, Dartmouth-Hitchcock Medical Center, Hanover, NH 9/23/13 “Infective endocarditis” Internal Medicine teaching conference. Santa Clara Valley Medical Center, San Jose, CA 11/14/13 “Urinary tract infections” Health and Human Diseases lecture series, Stanford University School of Medicine, Stanford, CA 11/27/13 “A young man with altered mental status following head trauma” Emergency Medicine/Critical Care Medicine Grand Rounds, Stanford University School of Medicine, Stanford, CA 1/29/14 “Beta lactam antibiotics” Internal Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 2/18/14 “Infective endocarditis” Infectious Disease Fellowship core lecture, Stanford University School of Medicine, Stanford, CA 2/22/14 “ID and tropical medicine for surgical care” International Humanitarian Surgery Skills Course, Stanford University School of Medicine, Stanford, CA 2/25/14 “Urinary tract infections” Infectious Disease Fellowship core lecture, Stanford University School of Medicine, Stanford, CA 2/28/14 “Antibiotic resistance” Pediatric Infectious Diseases research conference, Stanford University School of Medicine, Stanford, CA 3/7/14 “Military service-related injury and illness: Veterans’ health and occupational medicine” Occupational and Environmental Factors in Infectious Disease and Updates in Occupational Health, University of California San Francisco, San Francisco, CA 3/24/14 “A veteran with back pain following Staphylococcal bacteremia” Medicine Morbidity and Mortality conference, Stanford University School of Medicine, Stanford, CA 3/27/14 “From Bagram Airfield to Baghdad and back again” Invited lecture, Hiller Aviation Museum, San Carlos, CA 6/26/14 “How to do an ID consult” Orientation for Stanford ID fellows, Stanford University School of Medicine, Stanford, CA 8/13/14 “Ebola virus—the pathogen, epidemiology, disease, and control” Stanford Center for Medical Education Research and Innovation, Stanford University School of Medicine, Stanford, CA 8/14/14 “HIV-related opportunistic infections” Dean L. Winslow, M.D. Curriculum Vitae - Page 38 Department of Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 9/9/14 “Infective Endocarditis” Core lecture, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA 9/16/14 “Urinary tract infections” Core lecture, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA 9/18/14 “Pneumocystis pneumonia” Infectious Diseases Grand Rounds, Stanford University School of Medicine, Stanford, CA 9/30/14 “Necrotizing fasciitis” Department of Medicine Morbidity and Mortality Conference, Stanford University School of Medicine, Stanford, CA 11/19/14 “Skin rash and eosinophilia following treatment with a Beta lactam antibiotic” Medical Grand Rounds, Stanford University School of Medicine, Stanford, CA 11/20/14 “From Bagram Airfield to Baghdad and back again” Military Officers Association of America, San Francisco, CA 1/21/15 “Delayed diagnosis of a GU abscess” VAMC Multidisciplinary Conference, VAMC Palo Alto, Palo Alto, CA 2/4/15 “Beta lactam and other cell wall-active antibiotics” Division of Pulmonary Disease and Critical Care Medicine conference, Stanford University School of Medicine, Stanford, CA 2/25/15 “Antibiotics II” Division of Pulmonary Disease and Critical Care Medicine conference Stanford University School of Medicine, Stanford, CA 2/27/15 “Childhood exanthems” Department of Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 4/28/15 “Solid organ transplant recipient with fever, hypotension, and refractory seizures” Department of Medicine Morbidity and Mortality Conference, Stanford University School of Medicine, Stanford, CA 6/26/15 “A military doctor’s experience in two wars” Department of Medicine teaching conference, Stanford University School of Medicine and VA Palo Alto, Stanford, CA 7/28/15 “Fever and pleural effusion in a foreign-born patient” Department of Medicine Morbidity and Mortality Conference, Stanford University School of Medicine, Stanford, CA 8/21/15 “Mechanisms of antibiotic resistance” Pediatric Infectious Diseases fellowship core lecture, Stanford/Lucile Packard Children’s Hospital, Stanford, CA 8/24/15 “Infective endocarditis” Dean L. Winslow, M.D. Curriculum Vitae - Page 39 Department of Medicine teaching conference, Stanford University School of Medicine and VA Palo Alto, Stanford, CA 8/25/15 “Central line associated blood stream infection in a patient with ‘chronic Lyme disease’” Department of Medicine Morbidity and Mortality Conference, Stanford University School of Medicine, Stanford, CA 10/29/15 “Caring for all in war and peace” American Correctional Health Services Association Annual Meeting, Sacramento, CA 11/10/15 “From Bagram Airfield to Baghdad and back again” Grand Rounds, Mills Peninsula Medical Center, Burlingame, CA 1/19/16 “Beta lactam antibiotics” Department of Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 1/27/16 “From Bagram Airfield to Baghdad and back again” Combined Grand Rounds, Uniformed Services University of Health Sciences, Washington, DC 2/22/16 “HIV-related opportunistic infections” Department of Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 3/1/16 Panel discussant—Resources for veterans in Northern California Dominican University, San Rafael, CA 3/11/16 “Combat casualty care in our wars in Afghanistan and Iraq” Queen’s Club, Alameda Naval Air Station, CA 4/22/16 “Childhood exanthems” Department of Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 6/28/16 “A young woman with a rapidly progressing multi-system illness” Department of Medicine Morbidity and Mortality Conference, Stanford University School of Medicine, Stanford, CA 8/5/16 “From Bagram Airfield to Baghdad and back again” Department of Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 9/2/16 “Infective endocarditis” Department of Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 9/7/16 “A morbid taste for bones- a patient with disseminated MAC infection and anticytokine antibodies” Medicine Grand Rounds, Stanford University School of Medicine, Stanford, CA 9/29/16 “From Bagram Airfield to Baghdad and back again- a U.S. military doctor’s experience in two wars” Medicine Grand Rounds, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA Dean L. Winslow, M.D. Curriculum Vitae - Page 40 11/1/16 “Infective endocarditis” Division of Infectious Diseases teaching conference, Stanford University School of Medicine, Stanford, CA 11/8/16 “Urinary tract infections” Division of Infectious Diseases teaching conference, Stanford University School of Medicine, Stanford, CA 11/9/16 “From Bagram Airfield to Baghdad and back again- a U.S. military doctor’s experience in two wars” Medicine Grand Rounds, University of Arizona, Tucson, AZ “HIV opportunistic infections” Department of Medicine teaching conference, Stanford University School of Medicine, Stanford, CA 11/14/16 11/21/16 “Infections involving the nervous system” Department of Neurology invited lecture, Stanford University School of Medicine, Stanford, CA
